ActivityActivity(AKT1(), Activity, increases, PIK3CB(), Activity)	AKT1({'UP': u'P31749'}), PIK3CB({'UP': u'P42338'})	PMC3690480	These findings revise our understanding of the regulation of type I PI3K by showing that both RAS and RHO family GTPases directly regulate distinct ubiquitous PI3K isoforms and that RAC activates p110beta downstream of GPCRs.
ActivityActivity(AKT1(), Activity, increases, PIK3CB(), Activity)	AKT1({'UP': u'P31749'}), PIK3CB({'UP': u'P42338'})	PMC3690480	RAC is activated in proximity to p110beta and binds to the RBD to fully activate p110beta lipid kinase activity (schematic in F).
ActivityActivity(AKT1(), Activity, increases, PIK3CB(), Activity)	AKT1({'UP': u'P31749'}), PIK3CB({'UP': u'P42338'})	PMC3690480	RAC Activates p110beta Downstream of GPCRs
ActivityActivity(AKT1(), Activity, increases, PIK3CB(), Activity)	AKT1({'UP': u'P31749'}), PIK3CB({'UP': u'P42338'})	PMC3690480	(G) RAC and CDC42 activate p110beta wild-type but not p110beta-RBD-DM in transfected cells.
ActivityActivity(AKT1(), Activity, increases, PIK3CB(), Activity)	AKT1({'UP': u'P31749'}), PIK3CB({'UP': u'P42338'})	PMC3690480	RAC Activates p110beta Downstream of G Protein Coupled Receptors, Related to
ActivityActivity(Akt1(), Activity, decreases, MAPK3(), Activity)	Akt1({'UP': u'P31750'}), MAPK3({'UP': u'P27361'})	PMC4345513	In summary, we showed that the PI3K-Akt signaling pathway negatively regulates Erk1 and 2 through induction of MKP3 expression in NIH3T3 cells expressing constitutively active Ras.
ActivityActivity(Akt1(), Activity, decreases, RAF1(), Activity)	Akt1({'UP': u'P31750'}), RAF1({'UP': u'P04049'})	PMC4345513	On the contrary, Akt can inhibit the Raf through phosphorylation on Ser-259,.
ActivityActivity(BIRC3(), Activity, decreases, DUSP6(), Activity)	BIRC3({'UP': u'Q13489'}), DUSP6({'UP': u'Q16828'})	PMC4345513	Treatment with either the PI3K inhibitor (LY294002) or the Akt inhibitor (API-2) blocked doxycycline induced accumulation of MKP3, which led to the partial recovery of the phosphorylation status of Erk1 and 2 (A), suggesting the existence of an alternative mechanism.
ActivityActivity(BIRC3(), Activity, decreases, DUSP6(), Activity)	BIRC3({'UP': u'Q13489'}), DUSP6({'UP': u'Q16828'})	PMC4345513	Moreover, doxycycline induced MKP3 promoter activity was strongly inhibited by LY294002 or API-2, whereas only slightly, but significantly, inhibited in the presence of U0126 (B).
ActivityActivity(BRAF(), Activity, decreases, ERK(), Activity)	BRAF({}), ERK({'IP': u'IPR008349'})	PMC3178447	They report that only selective BRAF inhibitors activate CRAF and ERK signaling, whereas pan-RAF inhibitors do not.
ActivityActivity(BRAF(), Activity, decreases, RAF1(), Activity)	BRAF({}), RAF1({'UP': u'P04049'})	PMC3178447	They report that only selective BRAF inhibitors activate CRAF and ERK signaling, whereas pan-RAF inhibitors do not.
ActivityActivity(CBFA2T2(), Activity, increases, PI3(), Activity)	CBFA2T2({'UP': u'O43439'}), PI3({'UP': u'P19957'})	PMC534114	However there have been several reports suggesting that Shp2 may specifically de-phosphorylate the tyrosine phosphorylation sites on Gab1 that bind to p85, thus terminating recruitment of PI-3 kinase and EGF induced activation of the PI-3 kinase pathway [-].
ActivityActivity(CDC42(), Activity, increases, PI3K(), Activity)	CDC42({'UP': u'P60953'}), PI3K({'UP': u'P42347'})	PMC3690480	Taken together, these findings indicate that RAC1 and CDC42 activate PI3K in living cells by isoform specific regulation of p110beta through its RBD.
ActivityActivity(CDC42(), Activity, increases, PIK3CB(), Activity)	CDC42({'UP': u'P60953'}), PIK3CB({'UP': u'P42338'})	PMC3690480	Strikingly, GTPgammaS loaded RAC1 or CDC42 strongly stimulated p110beta lipid kinase activity invitro (G), alone and in cooperation with a phosphotyrosine peptide (pY740), or when p110beta was complexed with a less inhibitory, truncated p85 (Deltap85 schematic in C).
ActivityActivity(CDC42(), Activity, increases, PIK3CB(), Activity)	CDC42({'UP': u'P60953'}), PIK3CB({'UP': u'P42338'})	PMC3690480	Although single knockdowns had only minor effects, combined knockdownof RAC1 and CDC42 significantly lowered phospho-AKT levels in wild-type, but not in p110beta-RBD-DM cells, closing the gap in steady-state phospho-AKT levels between the genotypes and suggesting that endogenous RAC1 and CDC42 cooperatively activate p110beta via its RBD.
ActivityActivity(CDC42(), Activity, increases, PIK3CB(), Activity)	CDC42({'UP': u'P60953'}), PIK3CB({'UP': u'P42338'})	PMC3690480	(I) RAC1 and CDC42 activate p110beta in cells.
ActivityActivity(CDC42(), Activity, increases, PIK3CB(), Activity)	CDC42({'UP': u'P60953'}), PIK3CB({'UP': u'P42338'})	PMC3690480	(H) RAC1 and CDC42 activate p110beta invivo.
ActivityActivity(CDC42(), Activity, increases, PIK3CB(), Activity)	CDC42({'UP': u'P60953'}), PIK3CB({'UP': u'P42338'})	PMC3690480	(G) RAC and CDC42 activate p110beta wild-type but not p110beta-RBD-DM in transfected cells.
ActivityActivity(DOCK1(), Activity, increases, AKT1(), Activity)	DOCK1({'UP': u'Q14185'}), AKT1({'UP': u'P31749'})	PMC3690480	Dock180 and Elmo1 Activate RAC Downstream of GPCRs and Upstream of p110beta
ActivityActivity(DOCK1(), Activity, increases, AKT1(), Activity)	DOCK1({'UP': u'Q14185'}), AKT1({'UP': u'P31749'})	PMC3690480	Dock180 and Elmo1 Activate RAC Downstream of GPCRs and Upstream of p110beta, Related to
ActivityActivity(DOCK1(), Activity, increases, PIK3CB(), Activity)	DOCK1({'UP': u'Q14185'}), PIK3CB({'UP': u'P42338'})	PMC3690480	Dock180 and Elmo1 Activates RAC Downstream of GPCRs and Upstream of p110beta
ActivityActivity(DOCK1(), Activity, increases, PIK3CB(), Activity)	DOCK1({'UP': u'Q14185'}), PIK3CB({'UP': u'P42338'})	PMC3690480	Dock180 and Elmo1 Activate RAC Downstream of GPCRs and Upstream of p110beta
ActivityActivity(DOCK1(), Activity, increases, PIK3CB(), Activity)	DOCK1({'UP': u'Q14185'}), PIK3CB({'UP': u'P42338'})	PMC3690480	Dock180 and Elmo1 Activate RAC Downstream of GPCRs and Upstream of p110beta, Related to
ActivityActivity(DUSP6(), Activity, decreases, Erk(), Activity)	DUSP6({'UP': u'Q16828'}), Erk({'IP': u'IPR008349'})	PMC4345513	Our results demonstrated that the Ras/Raf/MEK / Erk signaling cascade is negatively regulated by the PI3K and Aktdependent transcriptional activation of the MKP3 gene.
ActivityActivity(EGF(), Activity, increases, AKT1(), Activity)	EGF({'UP': u'P01133'}), AKT1({'UP': u'P31749'})	PMC3690480	Moreover, knockdown of Dock180 abolished LPA- but not EGF induced RAC activation (C), firmly placing Dock180 and Elmo1 downstream of the LPA receptor and upstream of RAC and p110beta.
ActivityActivity(EGF(), Activity, increases, Akt1(), Activity)	EGF({'UP': u'P01133'}), Akt1({'UP': u'P31750'})	PMC534114	As the autophosphorylation sites on EGF-receptor (EGFR) do not include canonical PI-3 kinase binding sites, it is thought that EGF stimulation of PI-3 kinase and its downstream effector Akt is mediated by an indirect mechanism.
ActivityActivity(EGF(), Activity, increases, Akt1(), Activity)	EGF({'UP': u'P01133'}), Akt1({'UP': u'P31750'})	PMC534114	We demonstrate that Gab1 is essential for EGF stimulation of PI-3 kinase and Akt in these cells and that these responses are mediated by complex formation between p85, the regulatory subunit of PI-3 kinase, and three canonical tyrosine phosphorylation sites on Gab1.
ActivityActivity(EGF(), Activity, increases, Akt1(), Activity)	EGF({'UP': u'P01133'}), Akt1({'UP': u'P31750'})	PMC534114	However, in cells expressing ErbB3, EGF and neuroregulin can stimulate PI-3 kinase and Akt activation in a Gab1 dependent or Gab1 independent manner.
ActivityActivity(EGF(), Activity, increases, Akt1(), Activity)	EGF({'UP': u'P01133'}), Akt1({'UP': u'P31750'})	PMC534114	In the experiments presented here we utilized fibroblasts isolated from Gab1-/- mouse embryos in order to examine the role of Gab1 in EGF mediated activation of the PI-3 kinase and Akt cell survival pathway.
ActivityActivity(EGF(), Activity, increases, Akt1(), Activity)	EGF({'UP': u'P01133'}), Akt1({'UP': u'P31750'})	PMC534114	In this report we use MEFs derived from Gab1 -/ - embryos to explore the contribution of Gab1 and ErbB3 to EGF stimulation of PI-3 kinase and Akt in these cells.
ActivityActivity(EGF(), Activity, increases, Akt1(), Activity)	EGF({'UP': u'P01133'}), Akt1({'UP': u'P31750'})	PMC534114	Gab1 is essential for EGF stimulation of PI-3 kinase and Akt
ActivityActivity(EGF(), Activity, increases, Akt1(), Activity)	EGF({'UP': u'P01133'}), Akt1({'UP': u'P31750'})	PMC534114	As shown in Figure (top and middle panels), Gab1 -/ - cells display no activation of Akt in response to EGF, while WT MEFs show EGF stimulated Akt activation within two minutes of EGF treatment.
ActivityActivity(EGF(), Activity, increases, Akt1(), Activity)	EGF({'UP': u'P01133'}), Akt1({'UP': u'P31750'})	PMC534114	Taken together, these results demonstrate that Gab1 is required for EGF stimulation of PI-3 kinase and Akt.
ActivityActivity(EGF(), Activity, increases, Akt1(), Activity)	EGF({'UP': u'P01133'}), Akt1({'UP': u'P31750'})	PMC534114	The experiment presented in Fig shows that ectopic expression of Gab1 in the Gab1 deficient cells rescues EGF induced Akt activation to levels similar to those observed in EGF treated wild type MEFs.
ActivityActivity(EGF(), Activity, increases, Akt1(), Activity)	EGF({'UP': u'P01133'}), Akt1({'UP': u'P31750'})	PMC534114	Mutation of the p85 binding sites on Gab1 essentially eliminated all EGF induced Akt activation relative to cells expressing wild type Gab1.
ActivityActivity(EGF(), Activity, increases, Akt1(), Activity)	EGF({'UP': u'P01133'}), Akt1({'UP': u'P31750'})	PMC534114	Expression of Gab1 mutant protein deficient in Shp2 binding rescues EGF induced PI-3 kinase and Akt activation in Gab1 -/ - MEFs
ActivityActivity(EGF(), Activity, increases, Akt1(), Activity)	EGF({'UP': u'P01133'}), Akt1({'UP': u'P31750'})	PMC534114	As expected, the additional mutation of the p85 binding sites (Gab1F446/472/589 / 627 and 659) limited Akt activation to levels similar to those observed in the Gab1 -/ - cells, confirming the requirement for PI-3 kinase association with Gab1 to induce EGF mediated activation of the Akt pathway.
ActivityActivity(EGF(), Activity, increases, Akt1(), Activity)	EGF({'UP': u'P01133'}), Akt1({'UP': u'P31750'})	PMC534114	In order to test the ability of ErbB3 to rescue the EGF induced activation of the PI-3 kinase and Akt signaling pathway in Gab1 -/ - MEFs, we first assayed these cells for EGF induced PI-3 kinase activity.
ActivityActivity(EGF(), Activity, increases, Akt1(), Activity)	EGF({'UP': u'P01133'}), Akt1({'UP': u'P31750'})	PMC534114	Taken together, these results demonstrate that ErbB3 can partially compensate for Gab1 deficiency in EGF induced activation of the PI-3 kinase and Akt signaling pathway, although Gab1 mediated activation appears to be more robust, and likely represents the primary mechanism by which EGF stimulates PI-3 kinase and Akt.
ActivityActivity(EGF(), Activity, increases, Akt1(), Activity)	EGF({'UP': u'P01133'}), Akt1({'UP': u'P31750'})	PMC534114	ErbB3 expression can bypass the requirement for Gab1 in EGFR signaling and can partially rescue EGF induced activation of the PI-3 kinase and Akt cell survival pathway.
ActivityActivity(EGF(), Activity, increases, Akt1(), Activity)	EGF({'UP': u'P01133'}), Akt1({'UP': u'P31750'})	PMC534114	Expression of wild type Gab1 rescues EGF induced PI-3 kinase and Akt activation in Gab1 deficient MEFs.
ActivityActivity(EGF(), Activity, increases, Akt1(), Activity)	EGF({'UP': u'P01133'}), Akt1({'UP': u'P31750'})	PMC534114	Ectopic expression of Gab1 in Gab1 -/ - MEFs rescues the EGF induced activation of Akt.
ActivityActivity(EGF(), Activity, increases, Akt1(), Activity)	EGF({'UP': u'P01133'}), Akt1({'UP': u'P31750'})	PMC534114	Ectopic expression of Gab1 in Gab1 -/ - MEFs rescues activation of Akt in response to EGF treatment, while expression of Gab1F446/472/589 fails to rescue the EGF induced Akt activation.
ActivityActivity(EGF(), Activity, increases, Akt1(), Activity)	EGF({'UP': u'P01133'}), Akt1({'UP': u'P31750'})	PMC534114	Expression of a Gab1 mutant protein deficient in Shp2 binding enhances EGF induced activation of the PI-3 kinase and Akt signaling pathway.
ActivityActivity(EGF(), Activity, increases, Akt1(), Activity)	EGF({'UP': u'P01133'}), Akt1({'UP': u'P31750'})	PMC534114	Expression of ErbB3 in Gab1 deficient MEFs partially rescues EGF induced activation of the PI-3 kinase and Akt signaling pathway.
ActivityActivity(EGF(), Activity, increases, EGFR(), Activity)	EGF({'UP': u'P01133'}), EGFR({'UP': u'P00533'})	PMC534114	All of the cell lines examined show similar kinetics of EGF induced EGFR activation.
ActivityActivity(EGF(), Activity, increases, EGFR(), Activity)	EGF({'UP': u'P01133'}), EGFR({'UP': u'P00533'})	PMC534114	All of the cell lines examined show similar kinetics of EGF induced EGFR activation.
ActivityActivity(EGF(), Activity, increases, GAB1(), Activity)	EGF({'UP': u'P01133'}), GAB1({'UP': u'Q13480'})	PMC534114	However, in cells expressing ErbB3, EGF and neuroregulin can stimulate PI-3 kinase and Akt activation in a Gab1 dependent or Gab1 independent manner.
ActivityActivity(EGF(), Activity, increases, GAB1(), Activity)	EGF({'UP': u'P01133'}), GAB1({'UP': u'Q13480'})	PMC534114	However, in cells expressing ErbB3, EGF and neuroregulin can stimulate PI-3 kinase and Akt activation in a Gab1 dependent or Gab1 independent manner.
ActivityActivity(EGF(), Activity, increases, GAB1(), Activity)	EGF({'UP': u'P01133'}), GAB1({'UP': u'Q13480'})	PMC534114	Expression of Gab1 mutant protein deficient in Shp2 binding rescues EGF induced PI-3 kinase and Akt activation in Gab1 -/ - MEFs
ActivityActivity(EGF(), Activity, increases, GAB1(), Activity)	EGF({'UP': u'P01133'}), GAB1({'UP': u'Q13480'})	PMC534114	To assess the role of the protein tyrosine phosphatase Shp2 in Gab1 mediated signaling induced by EGF, two Gab1 mutants were generated and expressed in pools of Gab1 -/ - MEFs.
ActivityActivity(EGF(), Activity, increases, GAB1(), Activity)	EGF({'UP': u'P01133'}), GAB1({'UP': u'Q13480'})	PMC534114	In both Gab1 and Gab1F627 and 659expressing cells the Gab1 associated PI-3 kinase activity is augmented by EGF treatment.
ActivityActivity(EGF(), Activity, increases, GAB1(), Activity)	EGF({'UP': u'P01133'}), GAB1({'UP': u'Q13480'})	PMC534114	Taken together, these results suggest a role for Shp2 in negatively regulating the EGF induced activation of the PI-3 kinase pathway via Gab1, possibly by dephosphorylating Gab1 at p85 binding sites.
ActivityActivity(EGF(), Activity, increases, GAB1(), Activity)	EGF({'UP': u'P01133'}), GAB1({'UP': u'Q13480'})	PMC534114	In order to test the ability of ErbB3 to rescue the EGF induced activation of the PI-3 kinase and Akt signaling pathway in Gab1 -/ - MEFs, we first assayed these cells for EGF induced PI-3 kinase activity.
ActivityActivity(EGF(), Activity, increases, GAB1(), Activity)	EGF({'UP': u'P01133'}), GAB1({'UP': u'Q13480'})	PMC534114	Expression of wild type Gab1 rescues EGF induced PI-3 kinase and Akt activation in Gab1 deficient MEFs.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	As the autophosphorylation sites on EGF-receptor (EGFR) do not include canonical PI-3 kinase binding sites, it is thought that EGF stimulation of PI-3 kinase and its downstream effector Akt is mediated by an indirect mechanism.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	We demonstrate that Gab1 is essential for EGF stimulation of PI-3 kinase and Akt in these cells and that these responses are mediated by complex formation between p85, the regulatory subunit of PI-3 kinase, and three canonical tyrosine phosphorylation sites on Gab1.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	We used fibroblasts isolated from Gab1-/- mouse embryos to explore the mechanism of EGF stimulation of the PI-3 kinase and Akt anti-apoptotic cell signaling pathway.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	However, in cells expressing ErbB3, EGF and neuroregulin can stimulate PI-3 kinase and Akt activation in a Gab1 dependent or Gab1 independent manner.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	EGF stimulation of PI-3 kinase may also be mediated by the docking protein Gab1 (Grb2 associated binder-1).
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	Although the role of the Shp2 protein in the control of EGFR and Gab1 interactions is not well understood, several studies have suggested that Gab1 associated Shp2 may influence EGF induced PI-3 kinase signaling.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	In the experiments presented here we utilized fibroblasts isolated from Gab1-/- mouse embryos in order to examine the role of Gab1 in EGF mediated activation of the PI-3 kinase and Akt cell survival pathway.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	In this report we use MEFs derived from Gab1 -/ - embryos to explore the contribution of Gab1 and ErbB3 to EGF stimulation of PI-3 kinase and Akt in these cells.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	Gab1 is essential for EGF stimulation of PI-3 kinase and Akt
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	As shown in Figure, Gab1 -/ - MEFs displayed very low levels of EGF induced PI-3 kinase activity relative to cells expressing Gab1.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	Taken together, these results demonstrate that Gab1 is required for EGF stimulation of PI-3 kinase and Akt.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	The low level of EGF induced PI-3 kinase activity observed in the Gab1 -/ - cells may be due to signaling via an alternate, Gab1 independent mechanism.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	Expression of Gab1 mutant protein deficient in Shp2 binding rescues EGF induced PI-3 kinase and Akt activation in Gab1 -/ - MEFs
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	Taken together, these results suggest a role for Shp2 in negatively regulating the EGF induced activation of the PI-3 kinase pathway via Gab1, possibly by dephosphorylating Gab1 at p85 binding sites.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	In order to test the ability of ErbB3 to rescue the EGF induced activation of the PI-3 kinase and Akt signaling pathway in Gab1 -/ - MEFs, we first assayed these cells for EGF induced PI-3 kinase activity.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	Thus, EGF and NRG can stimulate PI-3 kinase activation in normal and transfected cells by means of Gab1 and ErbB3, respectively.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	Taken together, these results demonstrate that ErbB3 can partially compensate for Gab1 deficiency in EGF induced activation of the PI-3 kinase and Akt signaling pathway, although Gab1 mediated activation appears to be more robust, and likely represents the primary mechanism by which EGF stimulates PI-3 kinase and Akt.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	While ErbB3 is relatively ineffective at mediating EGF stimulation of PI-3 kinase activation, it is an efficient mediator of PI-3 kinase stimulation in response to NRG stimulation.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	Interestingly, EGF induces PI-3 kinase activity to a greater degree in cells expressing Gab1 relative to cells expressing ErbB3.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	ErbB3 expression can bypass the requirement for Gab1 in EGFR signaling and can partially rescue EGF induced activation of the PI-3 kinase and Akt cell survival pathway.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	Gab1 -/ - cells fail to show phosphotyrosine associated PI-3 kinase activity, while cells expressing exogenous Gab1 display phosphotyrosine associated PI-3 kinase activity that is augmented by EGF treatment.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	Expression of wild type Gab1 rescues EGF induced PI-3 kinase and Akt activation in Gab1 deficient MEFs.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	Ectopic expression of wild type Gab1 restored EGF induced PI-3 kinase activity, while expression of Gab1F446/472/589 fails to rescue PI-3 kinase activity in response to EGF treatment.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	Expression of a Gab1 mutant protein deficient in Shp2 binding enhances EGF induced activation of the PI-3 kinase and Akt signaling pathway.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	Expression of ErbB3 in Gab1 deficient MEFs partially rescues EGF induced activation of the PI-3 kinase and Akt signaling pathway.
ActivityActivity(EGF(), Activity, increases, PI3(), Activity)	EGF({'UP': u'P01133'}), PI3({'UP': u'P19957'})	PMC534114	Expression of wild type Gab1 in Gab1 deficient MEFs rescues the EGF induced PI-3 kinase activity.
ActivityActivity(ELK1(), Activity, increases, Erk(), Activity)	ELK1({'UP': u'P19419'}), Erk({'IP': u'IPR008349'})	PMC4345513	Activated Erk phosphorylates several cytosolic signaling molecules, including p90 ribosomal S6 kinase (RSK), in the cytoplasm and translocates into the nucleus where it regulates many downstream targets, including the transcription factors Elk-1 and c-Jun, resulting in regulation of cell growth and differentiation.
ActivityActivity(ELMO1(), Activity, increases, AKT1(), Activity)	ELMO1({'UP': u'Q92556'}), AKT1({'UP': u'P31749'})	PMC3690480	Dock180 and Elmo1 Activate RAC Downstream of GPCRs and Upstream of p110beta
ActivityActivity(ELMO1(), Activity, increases, AKT1(), Activity)	ELMO1({'UP': u'Q92556'}), AKT1({'UP': u'P31749'})	PMC3690480	Dock180 and Elmo1 Activate RAC Downstream of GPCRs and Upstream of p110beta, Related to
ActivityActivity(ELMO1(), Activity, increases, PIK3CB(), Activity)	ELMO1({'UP': u'Q92556'}), PIK3CB({'UP': u'P42338'})	PMC3690480	Dock180 and Elmo1 Activates RAC Downstream of GPCRs and Upstream of p110beta
ActivityActivity(ELMO1(), Activity, increases, PIK3CB(), Activity)	ELMO1({'UP': u'Q92556'}), PIK3CB({'UP': u'P42338'})	PMC3690480	Dock180 and Elmo1 Activate RAC Downstream of GPCRs and Upstream of p110beta
ActivityActivity(ELMO1(), Activity, increases, PIK3CB(), Activity)	ELMO1({'UP': u'Q92556'}), PIK3CB({'UP': u'P42338'})	PMC3690480	Dock180 and Elmo1 Activate RAC Downstream of GPCRs and Upstream of p110beta, Related to
ActivityActivity(ERBB3(), Activity, increases, Akt1(), Activity)	ERBB3({'UP': u'P21860'}), Akt1({'UP': u'P31750'})	PMC534114	ErbB3 expression can bypass the requirement for Gab1 in EGFR signaling and can partially rescue EGF induced activation of the PI-3 kinase and Akt cell survival pathway.
ActivityActivity(ERBB3(), Activity, increases, Akt1(), Activity)	ERBB3({'UP': u'P21860'}), Akt1({'UP': u'P31750'})	PMC534114	Expression of ErbB3 in Gab1 deficient MEFs partially rescues EGF induced activation of the PI-3 kinase and Akt signaling pathway.
ActivityActivity(ERBB3(), Activity, increases, Akt1(), Activity)	ERBB3({'UP': u'P21860'}), Akt1({'UP': u'P31750'})	PMC534114	Ectopic expression of ErbB3 in Gab1 deficient cells results in a partial rescue of EGF induced Akt activation relative to cells expressing wild type Gab1.
ActivityActivity(ERBB3(), Activity, increases, EGF(), Activity)	ERBB3({'UP': u'P21860'}), EGF({'UP': u'P01133'})	PMC534114	ErbB3 expression can bypass the requirement for Gab1 in EGFR signaling and can partially rescue EGF induced activation of the PI-3 kinase and Akt cell survival pathway.
ActivityActivity(ERBB3(), Activity, increases, EGF(), Activity)	ERBB3({'UP': u'P21860'}), EGF({'UP': u'P01133'})	PMC534114	Expression of ErbB3 in Gab1 deficient MEFs partially rescues EGF induced activation of the PI-3 kinase and Akt signaling pathway.
ActivityActivity(ERBB3(), Activity, increases, PI3(), Activity)	ERBB3({'UP': u'P21860'}), PI3({'UP': u'P19957'})	PMC534114	Expression of ErbB3 in Gab1 -/ - MEFs enhances activation of the PI-3 kinase signaling pathway
ActivityActivity(ERBB3(), Activity, increases, PI3(), Activity)	ERBB3({'UP': u'P21860'}), PI3({'UP': u'P19957'})	PMC534114	ErbB3 expression can bypass the requirement for Gab1 in EGFR signaling and can partially rescue EGF induced activation of the PI-3 kinase and Akt cell survival pathway.
ActivityActivity(ERBB3(), Activity, increases, PI3(), Activity)	ERBB3({'UP': u'P21860'}), PI3({'UP': u'P19957'})	PMC534114	Expression of ErbB3 in Gab1 deficient MEFs partially rescues EGF induced activation of the PI-3 kinase and Akt signaling pathway.
ActivityActivity(ERK(), Activity, increases, MEK(), Activity)	ERK({'IP': u'IPR008349'}), MEK({})	PMC3178447	Sorafenib inhibited catCT421M in vitro and induced ERK signaling in cells expressing catCT421M, demonstrating that this mutant is capable of inhibitor induced MEK and ERK activation.
ActivityActivity(Estradiol(), Activity, increases, NCOA3(), Activity)	Estradiol({'CHEBI': u'42364'}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Estradiol induces a mobility change of SRC-3 on SDS-PAGE gels in an ER dependent manner.
ActivityActivity(Estradiol(), Activity, increases, esr1(), Activity)	Estradiol({'CHEBI': u'42364'}), esr1({'UP': u'P81559'})	PMC1234335	Estradiol induced SRC-3 phosphorylation requires ER.
ActivityActivity(Estradiol(), Activity, increases, esr1(), Activity)	Estradiol({'CHEBI': u'42364'}), esr1({'UP': u'P81559'})	PMC1234335	Estradiol increases ER nuclear localization.
ActivityActivity(Estradiol(), Activity, increases, localization(), Activity)	Estradiol({'CHEBI': u'42364'}), localization({'GO': u'0051179'})	PMC1234335	Estradiol increases ER nuclear localization.
ActivityActivity(GAB1(), Activity, increases, Akt1(), Activity)	GAB1({'UP': u'Q13480'}), Akt1({'UP': u'P31750'})	PMC534114	The experiment presented in Fig shows that ectopic expression of Gab1 in the Gab1 deficient cells rescues EGF induced Akt activation to levels similar to those observed in EGF treated wild type MEFs.
ActivityActivity(GAB1(), Activity, increases, Akt1(), Activity)	GAB1({'UP': u'Q13480'}), Akt1({'UP': u'P31750'})	PMC534114	The binding of p85 is absolutely required for Gab1 mediated activation of PI-3 kinase and Akt following EGF treatment.
ActivityActivity(GAB1(), Activity, increases, Akt1(), Activity)	GAB1({'UP': u'Q13480'}), Akt1({'UP': u'P31750'})	PMC534114	Expression of Gab1 mutant protein deficient in Shp2 binding rescues EGF induced PI-3 kinase and Akt activation in Gab1 -/ - MEFs
ActivityActivity(GAB1(), Activity, increases, Akt1(), Activity)	GAB1({'UP': u'Q13480'}), Akt1({'UP': u'P31750'})	PMC534114	Expression of wild type Gab1 rescues EGF induced PI-3 kinase and Akt activation in Gab1 deficient MEFs.
ActivityActivity(GAB1(), Activity, increases, Akt1(), Activity)	GAB1({'UP': u'Q13480'}), Akt1({'UP': u'P31750'})	PMC534114	Expression of a Gab1 mutant protein deficient in Shp2 binding enhances EGF induced activation of the PI-3 kinase and Akt signaling pathway.
ActivityActivity(GAB1(), Activity, increases, Akt1(), Activity)	GAB1({'UP': u'Q13480'}), Akt1({'UP': u'P31750'})	PMC534114	Ectopic expression of ErbB3 in Gab1 deficient cells results in a partial rescue of EGF induced Akt activation relative to cells expressing wild type Gab1.
ActivityActivity(GAB1(), Activity, increases, EGF(), Activity)	GAB1({'UP': u'Q13480'}), EGF({'UP': u'P01133'})	PMC534114	Expression of a Gab1 mutant protein deficient in Shp2 binding enhances EGF induced activation of the PI-3 kinase and Akt signaling pathway.
ActivityActivity(GAB1(), Activity, increases, PI3(), Activity)	GAB1({'UP': u'Q13480'}), PI3({'UP': u'P19957'})	PMC534114	The binding of p85 is absolutely required for Gab1 mediated activation of PI-3 kinase and Akt following EGF treatment.
ActivityActivity(GAB1(), Activity, increases, PI3(), Activity)	GAB1({'UP': u'Q13480'}), PI3({'UP': u'P19957'})	PMC534114	Expression of Gab1 mutant protein deficient in Shp2 binding rescues EGF induced PI-3 kinase and Akt activation in Gab1 -/ - MEFs
ActivityActivity(GAB1(), Activity, increases, PI3(), Activity)	GAB1({'UP': u'Q13480'}), PI3({'UP': u'P19957'})	PMC534114	Expression of ErbB3 in Gab1 -/ - MEFs enhances activation of the PI-3 kinase signaling pathway
ActivityActivity(GAB1(), Activity, increases, PI3(), Activity)	GAB1({'UP': u'Q13480'}), PI3({'UP': u'P19957'})	PMC534114	Expression of wild type Gab1 rescues EGF induced PI-3 kinase and Akt activation in Gab1 deficient MEFs.
ActivityActivity(GAB1(), Activity, increases, PI3(), Activity)	GAB1({'UP': u'Q13480'}), PI3({'UP': u'P19957'})	PMC534114	Ectopic expression of wild type Gab1 restored EGF induced PI-3 kinase activity, while expression of Gab1F446/472/589 fails to rescue PI-3 kinase activity in response to EGF treatment.
ActivityActivity(GAB1(), Activity, increases, PI3(), Activity)	GAB1({'UP': u'Q13480'}), PI3({'UP': u'P19957'})	PMC534114	Expression of a Gab1 mutant protein deficient in Shp2 binding enhances EGF induced activation of the PI-3 kinase and Akt signaling pathway.
ActivityActivity(GAB1(), Activity, increases, PI3(), Activity)	GAB1({'UP': u'Q13480'}), PI3({'UP': u'P19957'})	PMC534114	Expression of wild type Gab1 in Gab1 deficient MEFs rescues the EGF induced PI-3 kinase activity.
ActivityActivity(GBETA1(), Activity, increases, PIP2_7(), Activity)	GBETA1({'UP': u'O45040'}), PIP2_7({'UP': u'P93004'})	PMC3690480	PIP3 levels were further enhanced by coexpression of Gbeta1 and Ggamma2 subunits or by myristoylation of p110beta (I).
ActivityActivity(GCR2(), Activity, increases, PIK3CB(), Activity)	GCR2({'UP': u'F4IEM5'}), PIK3CB({'UP': u'P42338'})	PMC3690480	(F) Model of GPCR induced p110beta activation.
ActivityActivity(GTPases(), Activity, increases, PIK3CB(), Activity)	GTPases({}), PIK3CB({'UP': u'P42338'})	PMC3690480	Coexpression of constitutively active RAC1 or CDC42 (G, lanes 4-6), but not RHOA (H), along with p110beta and p85 in COS7 cells strongly elevated cellular phospho-AKT and PIP3 levels (I), indicating that both GTPases activate p110beta in transfected cells.
ActivityActivity(Ggamma2_subunits(), Activity, increases, PIP2_7(), Activity)	Ggamma2_subunits({}), PIP2_7({'UP': u'P93004'})	PMC3690480	PIP3 levels were further enhanced by coexpression of Gbeta1 and Ggamma2 subunits or by myristoylation of p110beta (I).
ActivityActivity(HRAS(), Activity, increases, PIK3CA(), Activity)	HRAS({'UP': u'P01112'}), PIK3CA({'UP': u'P42336'})	PMC3690480	Moreover, when we expressed constitutively active RAS or RAB5, along with p110alpha and p85 or p110beta and p85 in COS7 cells, and measured PIP3-levels (C) or steady-state phospho-AKT (A available online) as indicators of PI3K activity, HRAS and KRAS strongly enhanced p110alpha activity, whereas p110beta was not stimulated by either RAS proteins or RAB5.
ActivityActivity(ICI(), Activity, decreases, esr1(), Activity)	ICI({'HMDB': u'01874'}), esr1({'UP': u'P81559'})	PMC1234335	ICI treatment significantly reduced the level of total ERalpha as reported previously (13, 18, 54).
ActivityActivity(ITAM_bearing_receptors(), Activity, increases, PIK3CB(), Activity)	ITAM_bearing_receptors({}), PIK3CB({'UP': u'P42338'})	PMC3690480	Although we found no effect of tyrosine kinase inhibitors and no p85 tyrosine phosphorylation in response to LPA in support of such a mechanism in MEFs, there is evidence for cooperative GPCR and phosphotyrosine signaling to p110beta in leukocytes, and such a scenario appears possible in thrombocytes, where p110beta is activated by integrins, ITAM bearing receptors, and GPCRs.
ActivityActivity(JAB34(), Activity, increases, ERK(), Activity)	JAB34({}), ERK({'IP': u'IPR008349'})	PMC3178447	Finally, JAB34 induced ERK activation in cells coexpressing full-length V5-CRAFS428C / D486N and wild-type FLAG-CRAF, confirming that our model is valid in the context of full-length CRAF.
ActivityActivity(JAB34(), Activity, increases, ERK(), Activity)	JAB34({}), ERK({'IP': u'IPR008349'})	PMC3178447	JAB34 activated ERK signaling in cells coexpressing FLAG-BRAF with V5-catCS428C / D486N.
ActivityActivity(JAB34(), Activity, decreases, ERK(), Activity)	JAB34({}), ERK({'IP': u'IPR008349'})	PMC3178447	a, Similarly to RAF inhibitors, JAB34 inhibits MEK and ERK at higher concentrations.
ActivityActivity(JAB34(), Activity, decreases, MEK(), Activity)	JAB34({}), MEK({})	PMC3178447	a, Similarly to RAF inhibitors, JAB34 inhibits MEK and ERK at higher concentrations.
ActivityActivity(JAB34(), Activity, increases, V5_CRAFS428C(), Activity)	JAB34({}), V5_CRAFS428C({})	PMC3178447	Finally, JAB34 induced ERK activation in cells coexpressing full-length V5-CRAFS428C / D486N and wild-type FLAG-CRAF, confirming that our model is valid in the context of full-length CRAF.
ActivityActivity(JAB34(), Activity, increases, wild_type_FLAG_CRAF(), Activity)	JAB34({}), wild_type_FLAG_CRAF({})	PMC3178447	Finally, JAB34 induced ERK activation in cells coexpressing full-length V5-CRAFS428C / D486N and wild-type FLAG-CRAF, confirming that our model is valid in the context of full-length CRAF.
ActivityActivity(JUN(), Activity, increases, Erk(), Activity)	JUN({'UP': u'P05412'}), Erk({'IP': u'IPR008349'})	PMC4345513	Activated Erk phosphorylates several cytosolic signaling molecules, including p90 ribosomal S6 kinase (RSK), in the cytoplasm and translocates into the nucleus where it regulates many downstream targets, including the transcription factors Elk-1 and c-Jun, resulting in regulation of cell growth and differentiation.
ActivityActivity(KRAS(), Activity, increases, PIK3CA(), Activity)	KRAS({'UP': u'P01116'}), PIK3CA({'UP': u'P42336'})	PMC3690480	Moreover, when we expressed constitutively active RAS or RAB5, along with p110alpha and p85 or p110beta and p85 in COS7 cells, and measured PIP3-levels (C) or steady-state phospho-AKT (A available online) as indicators of PI3K activity, HRAS and KRAS strongly enhanced p110alpha activity, whereas p110beta was not stimulated by either RAS proteins or RAB5.
ActivityActivity(LPA(), Activity, increases, PI3K(), Activity)	LPA({'UP': u'P08519'}), PI3K({'UP': u'P42347'})	PMC3690480	(D) LPA induced RAC activation is PI3K independent.
ActivityActivity(LPA(), Activity, increases, PIK3CB(), Activity)	LPA({'UP': u'P08519'}), PIK3CB({'UP': u'P42338'})	PMC3690480	We therefore wondered whether the disruption of p110beta activation by LPA in p110beta-RBD-DM mice would be sufficient to affect experimental lung fibrosis.
ActivityActivity(Lapatinib(), Activity, decreases, ERBB2(), Activity)	Lapatinib({'HMDB': u'15388'}), ERBB2({'UP': u'P04626'})	PMC3178447	The HER2 inhibitor Lapatinib abolished basal and PLX4032 induced ERK signaling in these cells.
ActivityActivity(MAPK3(), Activity, increases, DUSP6(), Activity)	MAPK3({'UP': u'P27361'}), DUSP6({'UP': u'Q16828'})	PMC4345513	It has been reported that MKP3 is induced by Erk1 and 2 upon fibroblast growth factor 2 (FGF2) stimulation in NIH3T3 cells, suggesting that growth factor induced Erk1 and 2 activity could be controlled by negative feedback loops via Erk1 and 2-specific MKP3 expression.
ActivityActivity(MEK(), Activity, increases, ERK(), Activity)	MEK({}), ERK({'IP': u'IPR008349'})	PMC3178447	In 293H cells overexpressing BRAFV600E and in HT29 tumor cells with endogenous BRAFV600E, ERK signaling was inhibited by either PLX or a MEK inhibitor.
ActivityActivity(MEK(), Activity, increases, ERK(), Activity)	MEK({}), ERK({'IP': u'IPR008349'})	PMC3178447	MEK inhibitors block ERK signaling in all tumor and normal cells and the dose of the drug that can be administered is limited by toxicity.
ActivityActivity(NCOA3(), Activity, increases, esr1(), Activity)	NCOA3({'UP': u'Q9Y6Q9'}), esr1({'UP': u'P81559'})	PMC1234335	As shown in Fig. 3A, P did not induce SRC-3 phosphorylation in the presence of PR-B (lanes 5 and 6), although in parallel experiments E2 induced ER dependent SRC-3 phosphorylation (lanes 3 and 4).
ActivityActivity(Nrg(), Activity, increases, PI3(), Activity)	Nrg({'UP': u'P20241'}), PI3({'UP': u'P19957'})	PMC534114	Thus, EGF and NRG can stimulate PI-3 kinase activation in normal and transfected cells by means of Gab1 and ErbB3, respectively.
ActivityActivity(PD_168393(), Activity, increases, catCS428C(), Activity)	PD_168393({}), catCS428C({})	PMC3178447	Two inhibitors JAB13 and JAB34 (PD-168393) both inhibited catCS428C, but up to 30muM had no effect in vitro on catC.
ActivityActivity(PI3K(), Activity, increases, DUSP6(), Activity)	PI3K({'UP': u'P42347'}), DUSP6({'UP': u'Q16828'})	PMC4345513	Role of PI3K signaling in active Ras induced MKP3 expression.
ActivityActivity(PI3K(), Activity, decreases, Erk(), Activity)	PI3K({'UP': u'P42347'}), Erk({'IP': u'IPR008349'})	PMC4345513	Our results demonstrated that the Ras/Raf/MEK / Erk signaling cascade is negatively regulated by the PI3K and Aktdependent transcriptional activation of the MKP3 gene.
ActivityActivity(PI3K(), Activity, decreases, MAPK3(), Activity)	PI3K({'UP': u'P42347'}), MAPK3({'UP': u'P27361'})	PMC4345513	The PI3K pathway also inhibits Erk1 and 2 activity through up regulation of MKP3 expression in response to FGF8 stimulation during limb development.
ActivityActivity(PI3K(), Activity, increases, Ras(), Activity)	PI3K({'UP': u'P42347'}), Ras({'IP': u'IPR020849'})	PMC4345513	Role of PI3K signaling in active Ras induced MKP3 expression.
ActivityActivity(PI3K_isoforms(), Activity, increases, PIK3CB(), Activity)	PI3K_isoforms({}), PIK3CB({'UP': u'P42338'})	PMC3690480	The p110beta isoform of PI3K, however, is instead activated by the binding of RHO family members RAC and CDC42.
ActivityActivity(PIK3CB(), Activity, increases, LPA(), Activity)	PIK3CB({'UP': u'P42338'}), LPA({'UP': u'P08519'})	PMC3690480	By inference, the protection of p110beta-RBD-DM mice against bleomycin induced lung fibrosis, together with the reduced migration of p110beta-RBD-DM fibroblasts in LPA-gradients, suggests that p110beta activation downstream of LPA might be critical for fibroblast chemotaxis to sites of tissue damage invivo.
ActivityActivity(PIK3CB(), Activity, increases, PIK3CB(), Activity)	PIK3CB({'UP': u'P42338'}), PIK3CB({'UP': u'P42338'})	PMC3690480	A puzzling question is whether a cooperative effect of RBD interactor and Gbetagamma binding to p110beta can suffice to fully activate p110beta, or if additional phosphotyrosine input is required to overcome the strong inhibition of lipid kinase activity imposed by p85.
ActivityActivity(PIK3CB(), Activity, increases, PIK3CB(), Activity)	PIK3CB({'UP': u'P42338'}), PIK3CB({'UP': u'P42338'})	PMC3690480	The RAB5 binding site on p110beta remains to be determined, yet several findings argue against RAB5 binding to p110beta through the RBD : (1) binding of RAB5 is entirely unaffected by p110beta RBD mutations (C); (2) RAB5 does not appear to stimulate p110beta (C,; (3) the affinity between RAB5 and p110beta in solution appears to be significantly higher (data not shown) than for typical PI3K RBD interactors, suggesting a more stable interaction, allowing to effectively localize p110beta to RAB5-positve subcellular compartments.
ActivityActivity(PIK3CB(), Activity, increases, PIP2_7(), Activity)	PIK3CB({'UP': u'P42338'}), PIP2_7({'UP': u'P93004'})	PMC3690480	PIP3 levels were further enhanced by coexpression of Gbeta1 and Ggamma2 subunits or by myristoylation of p110beta (I).
ActivityActivity(PLX(), Activity, increases, RAS(), Activity)	PLX({'UP': u'P81565'}), RAS({'IP': u'IPR020849'})	PMC3178447	We focused mechanistic investigations on catC, in which PLX induced MEK and ERK activation is RAS independent.
ActivityActivity(PLX4032(), Activity, increases, ERK(), Activity)	PLX4032({}), ERK({'IP': u'IPR008349'})	PMC3178447	PLX4032 induced ERK signaling in SKBR3 breast cancer cells, in which RAS activation is HER2 dependent.
ActivityActivity(PLX4032(), Activity, increases, ERK(), Activity)	PLX4032({}), ERK({'IP': u'IPR008349'})	PMC3178447	The HER2 inhibitor Lapatinib abolished basal and PLX4032 induced ERK signaling in these cells.
ActivityActivity(PLX4032(), Activity, decreases, ERK(), Activity)	PLX4032({}), ERK({'IP': u'IPR008349'})	PMC3178447	In contrast, in 293H cells expressing FLAG tagged BRAFV600E, ERK signaling was inhibited by PLX4032.
ActivityActivity(PLX4032(), Activity, decreases, RAF1(), Activity)	PLX4032({}), RAF1({'UP': u'P04049'})	PMC3178447	These predictions have been borne out strikingly in a recent clinical trial of the RAF inhibitor PLX4032 -.
ActivityActivity(PLX4720(), Activity, increases, ERK(), Activity)	PLX4720({}), ERK({'IP': u'IPR008349'})	PMC3178447	Induction of ERK signaling by PLX4720 was rapid, reversible, and associated with increased phosphorylation of the ERK substrate RSK.
ActivityActivity(PTPN11(), Activity, decreases, EGF(), Activity)	PTPN11({'UP': u'Q06124'}), EGF({'UP': u'P01133'})	PMC534114	Additionally, we show that while Shp2 does not mediate global dephosphorylation of Gab1, it does appear to negatively regulate the EGF induced activation of PI-3 kinase through an undefined mechanism.
ActivityActivity(PTPN11(), Activity, increases, EGF(), Activity)	PTPN11({'UP': u'Q06124'}), EGF({'UP': u'P01133'})	PMC534114	We further demonstrated that the Gab1 and Shp2 complex is responsible for the negative regulation of the strength and duration of PI-3 kinase and Akt signaling in response to EGF previously observed in Shp2 -/ - cells.
ActivityActivity(RAC1(), Activity, increases, PI3K(), Activity)	RAC1({'UP': u'P63000'}), PI3K({'UP': u'P42347'})	PMC3690480	Taken together, these findings indicate that RAC1 and CDC42 activate PI3K in living cells by isoform specific regulation of p110beta through its RBD.
ActivityActivity(RAC1(), Activity, increases, PIK3CB(), Activity)	RAC1({'UP': u'P63000'}), PIK3CB({'UP': u'P42338'})	PMC3690480	Strikingly, GTPgammaS loaded RAC1 or CDC42 strongly stimulated p110beta lipid kinase activity invitro (G), alone and in cooperation with a phosphotyrosine peptide (pY740), or when p110beta was complexed with a less inhibitory, truncated p85 (Deltap85 schematic in C).
ActivityActivity(RAC1(), Activity, increases, PIK3CB(), Activity)	RAC1({'UP': u'P63000'}), PIK3CB({'UP': u'P42338'})	PMC3690480	Although single knockdowns had only minor effects, combined knockdownof RAC1 and CDC42 significantly lowered phospho-AKT levels in wild-type, but not in p110beta-RBD-DM cells, closing the gap in steady-state phospho-AKT levels between the genotypes and suggesting that endogenous RAC1 and CDC42 cooperatively activate p110beta via its RBD.
ActivityActivity(RAC1(), Activity, increases, PIK3CB(), Activity)	RAC1({'UP': u'P63000'}), PIK3CB({'UP': u'P42338'})	PMC3690480	(I) RAC1 and CDC42 activate p110beta in cells.
ActivityActivity(RAC1(), Activity, increases, PIK3CB(), Activity)	RAC1({'UP': u'P63000'}), PIK3CB({'UP': u'P42338'})	PMC3690480	(H) RAC1 and CDC42 activate p110beta invivo.
ActivityActivity(RAF1(), Activity, increases, ERK(), Activity)	RAF1({'UP': u'P04049'}), ERK({'IP': u'IPR008349'})	PMC3178447	We found that ATP-competitive RAF inhibitors inhibit ERK signaling in cells with mutant BRAF, but unexpectedly enhance signaling in cells with wild-type BRAF.
ActivityActivity(RAF1(), Activity, decreases, ERK(), Activity)	RAF1({'UP': u'P04049'}), ERK({'IP': u'IPR008349'})	PMC3178447	Six distinct ATP-competitive RAF inhibitors induced ERK activation in cells with wild-type BRAF, but inhibited signaling in mutant BRAFV600E cells (,, Data Not Shown (DNS), structures of compounds shown in, except that of PLX4032, which is unavailable).
ActivityActivity(RAF1(), Activity, increases, ERK(), Activity)	RAF1({'UP': u'P04049'}), ERK({'IP': u'IPR008349'})	PMC3178447	We therefore investigated the mechanism of CRAF dependent induction of ERK signaling in response to the drug.
ActivityActivity(RAF1(), Activity, increases, ERK(), Activity)	RAF1({'UP': u'P04049'}), ERK({'IP': u'IPR008349'})	PMC3178447	The data suggest that binding of PLX to CRAF induces activation of the enzyme and, subsequently, ERK signaling.
ActivityActivity(RAF1(), Activity, decreases, ERK(), Activity)	RAF1({'UP': u'P04049'}), ERK({'IP': u'IPR008349'})	PMC3178447	Our data that all RAF inhibitors activate ERK signaling at low concentrations, that the phenomenon occurs in BRAF-null cells and that binding to CRAF activates CRAF and BRAF dependent ERK signaling render that model unlikely.
ActivityActivity(RAF1(), Activity, decreases, ERK(), Activity)	RAF1({'UP': u'P04049'}), ERK({'IP': u'IPR008349'})	PMC3178447	The transactivation model explains the observation that inhibitors of RAF activate ERK signaling at low concentrations, but inhibit at higher concentrations in BRAFwild-type cells.
ActivityActivity(RAF1(), Activity, increases, ERK(), Activity)	RAF1({'UP': u'P04049'}), ERK({'IP': u'IPR008349'})	PMC3178447	The data are consistent with the idea that RAF inhibitors suppress ERK signaling in BRAFV600E tumors because the level of RAS activation in these cells is insufficient to support transactivation of wild-type RAF and inhibition of BRAFV600E activity becomes the dominant effect of the drug.
ActivityActivity(RAF1(), Activity, decreases, ERK(), Activity)	RAF1({'UP': u'P04049'}), ERK({'IP': u'IPR008349'})	PMC3178447	RAF inhibitors rapidly activate MEK and ERK in cells with wild-type BRAF
ActivityActivity(RAF1(), Activity, decreases, MEK(), Activity)	RAF1({'UP': u'P04049'}), MEK({})	PMC3178447	RAF inhibitors rapidly activate MEK and ERK in cells with wild-type BRAF
ActivityActivity(RAF1(), Activity, increases, Ras(), Activity)	RAF1({'UP': u'P04049'}), Ras({'IP': u'IPR020849'})	PMC4345513	Activated Ras stimulates Raf kinases, which leads to activation of MAPK and Erk kinase (MEK).
ActivityActivity(RAS(), Activity, increases, PI3K(), Activity)	RAS({'IP': u'IPR020849'}), PI3K({'UP': u'P42347'})	PMC3690480	A very recent study using microscopy based assays in transfected cells revisited the interaction of small GTPases and PI3K, confirming that both active RAS and RHO family GTPases can activate PI3K in living cells.
ActivityActivity(RAS(), Activity, increases, PI3K_isoforms(), Activity)	RAS({'IP': u'IPR020849'}), PI3K_isoforms({})	PMC3690480	These findings revise our understanding of the regulation of type I PI3K by showing that both RAS and RHO family GTPases directly regulate distinct ubiquitous PI3K isoforms and that RAC activates p110beta downstream of GPCRs.
ActivityActivity(RAS(), Activity, increases, PIK3CB(), Activity)	RAS({'IP': u'IPR020849'}), PIK3CB({'UP': u'P42338'})	PMC3690480	It has, however, remained entirely unclear whether the p110beta RBD contributes to p110beta activation and function, and despite the apparently similar level of relatedness between the RBDs across the four isoforms, a systematic analysis of RAS effector proteins failed to detect any activation of p110beta by RAS in cotransfected cells.
ActivityActivity(RAS(), Activity, increases, type_I_PI3Ks(), Activity)	RAS({'IP': u'IPR020849'}), type_I_PI3Ks({})	PMC3690480	We find that out of the two ubiquitously expressed PI3K isoforms, only p110alpha is regulated by RAS, whereas p110beta is a direct RAC and CDC42 target protein, indicating that key members of the pivotal RAS and RHO families of small G proteins directly regulate type I PI3Ks, with each family controlling their own distinct ubiquitous p110 isoform.
ActivityActivity(RHO(), Activity, increases, PI3K(), Activity)	RHO({'IP': u'IPR003578'}), PI3K({'UP': u'P42347'})	PMC3690480	A very recent study using microscopy based assays in transfected cells revisited the interaction of small GTPases and PI3K, confirming that both active RAS and RHO family GTPases can activate PI3K in living cells.
ActivityActivity(RHO(), Activity, increases, PI3K_isoforms(), Activity)	RHO({'IP': u'IPR003578'}), PI3K_isoforms({})	PMC3690480	These findings revise our understanding of the regulation of type I PI3K by showing that both RAS and RHO family GTPases directly regulate distinct ubiquitous PI3K isoforms and that RAC activates p110beta downstream of GPCRs.
ActivityActivity(RHO(), Activity, increases, type_I_PI3Ks(), Activity)	RHO({'IP': u'IPR003578'}), type_I_PI3Ks({})	PMC3690480	We find that out of the two ubiquitously expressed PI3K isoforms, only p110alpha is regulated by RAS, whereas p110beta is a direct RAC and CDC42 target protein, indicating that key members of the pivotal RAS and RHO families of small G proteins directly regulate type I PI3Ks, with each family controlling their own distinct ubiquitous p110 isoform.
ActivityActivity(RHOA(), Activity, increases, PIK3CB(), Activity)	RHOA({'UP': u'P61586'}), PIK3CB({'UP': u'P42338'})	PMC3690480	(H) RAC1 and CDC42, but not RHOA activate p110beta in transfected cells.
ActivityActivity(Ras(), Activity, increases, DUSP6(), Activity)	Ras({'IP': u'IPR020849'}), DUSP6({'UP': u'Q16828'})	PMC4345513	Inhibition of the phosphatidylinositol 3-kinase (PI3K) / Akt pathway abrogated active Ras induced up regulation of MKP3 expression, leading to the rescue of Erk1 and 2 phosphorylation.
ActivityActivity(Ras(), Activity, increases, DUSP6(), Activity)	Ras({'IP': u'IPR020849'}), DUSP6({'UP': u'Q16828'})	PMC4345513	Northern blot analysis revealed that prolonged expression of active Ras increased MAP kinase phosphatase 3 (MKP3) mRNA expression, a negative regulator of Erk MAPK.
ActivityActivity(Ras(), Activity, increases, DUSP6(), Activity)	Ras({'IP': u'IPR020849'}), DUSP6({'UP': u'Q16828'})	PMC4345513	Northern blot analysis revealed that prolonged expression of active Ras increased MAP kinase phosphatase 3 (MKP3) mRNA expression, a negative regulator of Erk MAPK.
ActivityActivity(Ras(), Activity, increases, DUSP6(), Activity)	Ras({'IP': u'IPR020849'}), DUSP6({'UP': u'Q16828'})	PMC4345513	Thus, long-term activation of the Ras signaling pathway up-regulates MKP3 expression at the transcriptional level in NIH3T3 fibroblasts.
ActivityActivity(Ras(), Activity, increases, DUSP6(), Activity)	Ras({'IP': u'IPR020849'}), DUSP6({'UP': u'Q16828'})	PMC4345513	These data suggest that the PI3K pathway plays a critical role in MKP3 expression induced by active Ras activation.
ActivityActivity(Ras(), Activity, increases, DUSP6(), Activity)	Ras({'IP': u'IPR020849'}), DUSP6({'UP': u'Q16828'})	PMC4345513	Role of PI3K signaling in active Ras induced MKP3 expression.
ActivityActivity(Ras(), Activity, increases, DUSP6(), Activity)	Ras({'IP': u'IPR020849'}), DUSP6({'UP': u'Q16828'})	PMC4345513	It is speculated that transient activation of Ras by growth factor signaling may induce MKP3 expression through an Erk1 and 2-dependent Ets family transcription factor, but sustained activation of Ras may preferentially use the PI3K dependent pathway to induce MKP3 expression.
ActivityActivity(Ras(), Activity, increases, DUSP6(), Activity)	Ras({'IP': u'IPR020849'}), DUSP6({'UP': u'Q16828'})	PMC4345513	It is speculated that transient activation of Ras by growth factor signaling may induce MKP3 expression through an Erk1 and 2-dependent Ets family transcription factor, but sustained activation of Ras may preferentially use the PI3K dependent pathway to induce MKP3 expression.
ActivityActivity(Ras(), Activity, decreases, Erk_MAP(), Activity)	Ras({'IP': u'IPR020849'}), Erk_MAP({})	PMC4345513	Constitutively active Ras negatively regulates Erk MAP kinase through induction of MAP kinase phosphatase 3 (MKP3) in NIH3T3 cells
ActivityActivity(Ras(), Activity, increases, MAPK3(), Activity)	Ras({'IP': u'IPR020849'}), MAPK3({'UP': u'P27361'})	PMC4345513	The present study proposes a novel mechanism by which prolonged activation of active Ras can modulate Erk1 and 2 activity through induction of the MKP3 gene in NIH3T3 cells.
ActivityActivity(Ras(), Activity, increases, MAPK3(), Activity)	Ras({'IP': u'IPR020849'}), MAPK3({'UP': u'P27361'})	PMC4345513	However, it remains possible that other MKPs of the DUSP family could affect active Ras induced Erk1 and 2 activity.
ActivityActivity(Ras(), Activity, increases, PI3K(), Activity)	Ras({'IP': u'IPR020849'}), PI3K({'UP': u'P42347'})	PMC4345513	Active Ras can stimulate multiple effector pathways, including Raf and PI3K.
ActivityActivity(Ras(), Activity, increases, PI3K(), Activity)	Ras({'IP': u'IPR020849'}), PI3K({'UP': u'P42347'})	PMC4345513	Ras positively cross-talks through direct interaction with the p110 catalytic subunit of PI3K to promote PI3K pathway activation.
ActivityActivity(Ras(), Activity, increases, PTEN(), Activity)	Ras({'IP': u'IPR020849'}), PTEN({'IP': u'IPR017361'})	PMC4345513	In addition, constitutive Ras activation can promote the down regulation of PTEN, a lipid phosphatase which counterbalances the effects of PI3K by removing the phosphate from PIP3.
ActivityActivity(Ras(), Activity, increases, RAF1(), Activity)	Ras({'IP': u'IPR020849'}), RAF1({'UP': u'P04049'})	PMC4345513	Active Ras can stimulate multiple effector pathways, including Raf and PI3K.
ActivityActivity(RasV12(), Activity, increases, Akt1(), Activity)	RasV12({}), Akt1({'UP': u'P31750'})	PMC4345513	Furthermore, RasV12 induced MKP3 promoter activity was significantly abrogated by expression of dominant negative (DN) - Akt (D).
ActivityActivity(Sorafenib(), Activity, increases, ERK(), Activity)	Sorafenib({'HMDB': u'14542'}), ERK({'IP': u'IPR008349'})	PMC3178447	Sorafenib inhibited catCT421M in vitro and induced ERK signaling in cells expressing catCT421M, demonstrating that this mutant is capable of inhibitor induced MEK and ERK activation.
ActivityActivity(Sorafenib(), Activity, increases, ERK(), Activity)	Sorafenib({'HMDB': u'14542'}), ERK({'IP': u'IPR008349'})	PMC3178447	c, Sorafenib inhibits the gatekeeper mutant catCT421M protein in vitro and activates MEK and ERK in cells expressing it.
ActivityActivity(Sorafenib(), Activity, increases, MEK(), Activity)	Sorafenib({'HMDB': u'14542'}), MEK({})	PMC3178447	Sorafenib inhibited catCT421M in vitro and induced ERK signaling in cells expressing catCT421M, demonstrating that this mutant is capable of inhibitor induced MEK and ERK activation.
ActivityActivity(Sorafenib(), Activity, increases, MEK(), Activity)	Sorafenib({'HMDB': u'14542'}), MEK({})	PMC3178447	c, Sorafenib inhibits the gatekeeper mutant catCT421M protein in vitro and activates MEK and ERK in cells expressing it.
ActivityActivity(Sorafenib(), Activity, decreases, catCT421M(), Activity)	Sorafenib({'HMDB': u'14542'}), catCT421M({})	PMC3178447	Sorafenib inhibited catCT421M in vitro and induced ERK signaling in cells expressing catCT421M, demonstrating that this mutant is capable of inhibitor induced MEK and ERK activation.
ActivityActivity(Sorafenib(), Activity, decreases, mutant_catCT421M_protein(), Activity)	Sorafenib({'HMDB': u'14542'}), mutant_catCT421M_protein({})	PMC3178447	c, Sorafenib inhibits the gatekeeper mutant catCT421M protein in vitro and activates MEK and ERK in cells expressing it.
ActivityActivity(doxycycline(), Activity, increases, DUSP6(), Activity)	doxycycline({'CHEBI': u'4713'}), DUSP6({'UP': u'Q16828'})	PMC4345513	MKP3 protein was also increased by doxycycline treatment and coincided with a reduction in Erk1 and 2 phosphorylation (B).
ActivityActivity(doxycycline(), Activity, increases, DUSP6(), Activity)	doxycycline({'CHEBI': u'4713'}), DUSP6({'UP': u'Q16828'})	PMC4345513	Treatment with either the PI3K inhibitor (LY294002) or the Akt inhibitor (API-2) blocked doxycycline induced accumulation of MKP3, which led to the partial recovery of the phosphorylation status of Erk1 and 2 (A), suggesting the existence of an alternative mechanism.
ActivityActivity(doxycycline(), Activity, increases, DUSP6(), Activity)	doxycycline({'CHEBI': u'4713'}), DUSP6({'UP': u'Q16828'})	PMC4345513	In contrast, the mTOR inhibitor rapamycin had no significant effect on doxycycline induced MKP3 promoter activity.
ActivityActivity(esr1(), Activity, increases, NCOA3(), Activity)	esr1({'UP': u'P81559'}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	It has been shown that both ER and SRC-3 shuttle between the cytoplasm and the nucleus (14, 39, 53), and the collective data indicate that SRC-3 phosphorylation can occur in both cytoplasm and nucleus and that it generally promotes nuclear localization of SRC-3 (53, 68, 71, 74).
ActivityActivity(esr1(), Activity, increases, alpha(), Activity)	esr1({'UP': u'P81559'}), alpha({'CHEBI': u'30216'})	PMC1234335	Consistent with these data, mutation of any of the six phosphorylation sites to an alanine residue impairs the ability of the mutant SRC 3 to coactivate E2 induced estrogen receptor alpha (ERalpha) target gene expression in reporter assays, while all but S860 mutations affect TNF-alpha-induced NF-kappaB target gene activation.
ActivityActivity(esr1(), Activity, increases, localization(), Activity)	esr1({'UP': u'P81559'}), localization({'GO': u'0051179'})	PMC1234335	It has been shown that both ER and SRC-3 shuttle between the cytoplasm and the nucleus (14, 39, 53), and the collective data indicate that SRC-3 phosphorylation can occur in both cytoplasm and nucleus and that it generally promotes nuclear localization of SRC-3 (53, 68, 71, 74).
ActivityActivity(esr1(), Activity, increases, transcription(), Activity)	esr1({'UP': u'P81559'}), transcription({'GO': u'0006351'})	PMC1234335	Estradiol can induce cellular responses through direct " genomic " ER dependent activation of gene transcription at target promoters as well as by " nongenomic " actions, the latter including rapid activation of various protein kinase cascades independent of prior gene transcription (3).
ActivityActivity(integrins(), Activity, increases, PIK3CB(), Activity)	integrins({}), PIK3CB({'UP': u'P42338'})	PMC3690480	Although we found no effect of tyrosine kinase inhibitors and no p85 tyrosine phosphorylation in response to LPA in support of such a mechanism in MEFs, there is evidence for cooperative GPCR and phosphotyrosine signaling to p110beta in leukocytes, and such a scenario appears possible in thrombocytes, where p110beta is activated by integrins, ITAM bearing receptors, and GPCRs.
ActivityActivity(neuroregulin(), Activity, increases, Akt1(), Activity)	neuroregulin({}), Akt1({'UP': u'P31750'})	PMC534114	However, in cells expressing ErbB3, EGF and neuroregulin can stimulate PI-3 kinase and Akt activation in a Gab1 dependent or Gab1 independent manner.
ActivityActivity(neuroregulin(), Activity, increases, GAB1(), Activity)	neuroregulin({}), GAB1({'UP': u'Q13480'})	PMC534114	However, in cells expressing ErbB3, EGF and neuroregulin can stimulate PI-3 kinase and Akt activation in a Gab1 dependent or Gab1 independent manner.
ActivityActivity(neuroregulin(), Activity, increases, GAB1(), Activity)	neuroregulin({}), GAB1({'UP': u'Q13480'})	PMC534114	However, in cells expressing ErbB3, EGF and neuroregulin can stimulate PI-3 kinase and Akt activation in a Gab1 dependent or Gab1 independent manner.
ActivityActivity(neuroregulin(), Activity, increases, PI3(), Activity)	neuroregulin({}), PI3({'UP': u'P19957'})	PMC534114	However, in cells expressing ErbB3, EGF and neuroregulin can stimulate PI-3 kinase and Akt activation in a Gab1 dependent or Gab1 independent manner.
ActivityActivity(pelp1(), Activity, increases, esr1(), Activity)	pelp1({'UP': u'Q58HI1'}), esr1({'UP': u'P81559'})	PMC1234335	For example, E2 can induce a rapid and transient activation of the Src and Erk phosphorylation cascade through the association between cytoplasm localized ERalpha and MNAR (modulator of nongenomic activity of ER) (73).
ActivityActivity(rapamycin(), Activity, decreases, MTOR(), Activity)	rapamycin({'CHEBI': u'9168'}), MTOR({'UP': u'P42345'})	PMC4345513	In contrast, the mTOR inhibitor rapamycin had no significant effect on doxycycline induced MKP3 promoter activity.
ActivityActivity(small_G_proteins(), Activity, increases, type_I_PI3Ks(), Activity)	small_G_proteins({}), type_I_PI3Ks({})	PMC3690480	We find that out of the two ubiquitously expressed PI3K isoforms, only p110alpha is regulated by RAS, whereas p110beta is a direct RAC and CDC42 target protein, indicating that key members of the pivotal RAS and RHO families of small G proteins directly regulate type I PI3Ks, with each family controlling their own distinct ubiquitous p110 isoform.
Complex(AKT1(), CBFA2T2())	AKT1({'UP': u'P31749'}), CBFA2T2({'UP': u'O43439'})	PMC3690480	Only the reported binding of RAC and CDC42 to recombinant p85 remains puzzling.
Complex(AKT1(), CDC42())	AKT1({'UP': u'P31749'}), CDC42({'UP': u'P60953'})	PMC3690480	To test whether the BCR homology domain (BHD) on p85, which had previously been shown to bind RAC and CDC42, is required for RAC and CDC42 binding to p110beta, we truncated p85 (Deltap85 schematic in C) and probed for binding of p110beta and Deltap85 to RAC1 and CDC42 invitro.
Complex(AKT1(), CDC42())	AKT1({'UP': u'P31749'}), CDC42({'UP': u'P60953'})	PMC3690480	Only the reported binding of RAC and CDC42 to recombinant p85 remains puzzling.
Complex(AKT1(), CDC42())	AKT1({'UP': u'P31749'}), CDC42({'UP': u'P60953'})	PMC3690480	An association of PI3K with RAC and CDC42 was first noticed nearly 20 years ago, but was attributed to RAC and CDC42 binding to the amino-terminal BHD on p85, which has sequence homology to RHO-GAP domains.
Complex(AKT1(), CDC42())	AKT1({'UP': u'P31749'}), CDC42({'UP': u'P60953'})	PMC3690480	(A) Single point mutations across the p110beta RBD disrupt binding to RAC and CDC42.
Complex(AKT1(), PIK3CB())	AKT1({'UP': u'P31749'}), PIK3CB({'UP': u'P42338'})	PMC3690480	RAC and CDC42 Binding to p110beta Controls PI3K Activity InVivo
Complex(AKT1(), PIK3CB())	AKT1({'UP': u'P31749'}), PIK3CB({'UP': u'P42338'})	PMC3690480	RAC and CDC42 Binding to p110beta Regulates PI3K Activity InVivo
Complex(AKT1(), PIK3CB())	AKT1({'UP': u'P31749'}), PIK3CB({'UP': u'P42338'})	PMC3690480	RAC and CDC42 Binding to p110beta Regulates PI3K Activity In Vivo, Related to
Complex(ARAF(), BRAF())	ARAF({'UP': u'P10398'}), BRAF({})	PMC3178447	PLX4032 inhibited ARAF, BRAF and CRAF immunoprecipitated from 293H cells and purified catalytic domains of BRAFV600E, wild-type BRAF and CRAF (IC50s : 35, 110 and 48nM).
Complex(ARAF(), RAF1())	ARAF({'UP': u'P10398'}), RAF1({'UP': u'P04049'})	PMC3178447	PLX4032 inhibited ARAF, BRAF and CRAF immunoprecipitated from 293H cells and purified catalytic domains of BRAFV600E, wild-type BRAF and CRAF (IC50s : 35, 110 and 48nM).
Complex(BRAF(), RAF1())	BRAF({}), RAF1({'UP': u'P04049'})	PMC3178447	PLX4032 inhibited ARAF, BRAF and CRAF immunoprecipitated from 293H cells and purified catalytic domains of BRAFV600E, wild-type BRAF and CRAF (IC50s : 35, 110 and 48nM).
Complex(BRAF(), RAF1())	BRAF({}), RAF1({'UP': u'P04049'})	PMC3178447	This is consistent with the enhancement of induction by active RAS, which promotes homo- and hetero-dimerization of BRAF and CRAF,.
Complex(BRAF(), RAF1())	BRAF({}), RAF1({'UP': u'P04049'})	PMC3178447	c, Activation in the context of the heterodimer BRAF and CRAF occurs in trans.
Complex(CBFA2T2(), GAB1())	CBFA2T2({'UP': u'O43439'}), GAB1({'UP': u'Q13480'})	PMC534114	These results are consistent with our finding that p85 binding to Gab1 does not influence the recruitment of Shp2 to the Gab1 signaling complex, and are inconsistent with the conclusion that Gab1 mediates a PI-3 kinase dependent recruitment of Shp2.
Complex(CBFA2T2(), GAB1())	CBFA2T2({'UP': u'O43439'}), GAB1({'UP': u'Q13480'})	PMC534114	These results are consistent with our finding that p85 binding to Gab1 does not influence the recruitment of Shp2 to the Gab1 signaling complex, and are inconsistent with the conclusion that Gab1 mediates a PI-3 kinase dependent recruitment of Shp2.
Complex(CBFA2T2(), RAC1())	CBFA2T2({'UP': u'O43439'}), RAC1({'UP': u'P63000'})	PMC3690480	Purified recombinant wild-type p110beta and p85 bound to RAC1 and CDC42 in a concentration dependent manner, whereas p110beta-RBD-DM and p85 complexes showed no binding (A).
Complex(CC(), NCOA3())	CC({'CHEBI': u'28940'}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	The CC mutant appeared to be less effective at supporting SRC-3 phosphorylation than wild-type ERalpha was (lanes 3 and 4) or the EG mutant, even though the CC mutant binds to SRC-3 as well as does the wild-type receptor.
Complex(CDC42(), CBFA2T2())	CDC42({'UP': u'P60953'}), CBFA2T2({'UP': u'O43439'})	PMC3690480	Only the reported binding of RAC and CDC42 to recombinant p85 remains puzzling.
Complex(CDC42(), PIK3CB())	CDC42({'UP': u'P60953'}), PIK3CB({'UP': u'P42338'})	PMC3690480	Taken together, these data show that the RHO family GTPases RAC1 and CDC42 bind to p110beta in an isoform specific manner and potently and directly stimulate its lipid kinase activity.
Complex(CDC42(), PIK3CB())	CDC42({'UP': u'P60953'}), PIK3CB({'UP': u'P42338'})	PMC3690480	To test whether the BCR homology domain (BHD) on p85, which had previously been shown to bind RAC and CDC42, is required for RAC and CDC42 binding to p110beta, we truncated p85 (Deltap85 schematic in C) and probed for binding of p110beta and Deltap85 to RAC1 and CDC42 invitro.
Complex(CDC42(), PIK3CB())	CDC42({'UP': u'P60953'}), PIK3CB({'UP': u'P42338'})	PMC3690480	We did not study monomeric p85, which has not been found in living cells, but our biochemical data strongly argue against an involvement of p85 in the RAC and CDC42-p 110beta interaction, because (1) RAC1 and CDC42 do not interact with p110alpha and p85 or p110delta and p85, (2) RAC1 and CDC42 bind normally to p110beta in the absence of the p85 BH domain, and (3) RBD point mutations abrogate RAC1 and CDC42 binding to p110beta in complex with full-length p85.
Complex(CDC42(), PIK3CB())	CDC42({'UP': u'P60953'}), PIK3CB({'UP': u'P42338'})	PMC3690480	We did not study monomeric p85, which has not been found in living cells, but our biochemical data strongly argue against an involvement of p85 in the RAC and CDC42-p 110beta interaction, because (1) RAC1 and CDC42 do not interact with p110alpha and p85 or p110delta and p85, (2) RAC1 and CDC42 bind normally to p110beta in the absence of the p85 BH domain, and (3) RBD point mutations abrogate RAC1 and CDC42 binding to p110beta in complex with full-length p85.
Complex(CDC42(), PIK3CB())	CDC42({'UP': u'P60953'}), PIK3CB({'UP': u'P42338'})	PMC3690480	RAC and CDC42 Binding to p110beta Controls PI3K Activity InVivo
Complex(CDC42(), PIK3CB())	CDC42({'UP': u'P60953'}), PIK3CB({'UP': u'P42338'})	PMC3690480	RAC and CDC42 Binding to p110beta Regulates PI3K Activity InVivo
Complex(CDC42(), PIK3CB())	CDC42({'UP': u'P60953'}), PIK3CB({'UP': u'P42338'})	PMC3690480	(D) RAC1 and CDC42 bind p110beta in a GTP dependent manner.
Complex(CDC42(), PIK3CB())	CDC42({'UP': u'P60953'}), PIK3CB({'UP': u'P42338'})	PMC3690480	RAC and CDC42 Binding to p110beta Regulates PI3K Activity In Vivo, Related to
Complex(DIRAS(), PIK3CA())	DIRAS({}), PIK3CA({'UP': u'P42336'})	PMC3690480	This substitution is relevant to PI3K binding because an HRAS D33I mutant showed attenuated binding to p110alpha and DIRAS1-I37D showed reduced binding to p110beta, even though exchange of this residue did not enable RAS binding to p110beta or DIRAS binding to p110alpha (A), pointing to additional, G2-box-independent determinants of PI3K isoform specificity.
Complex(DIRAS1(), PIK3CB())	DIRAS1({'UP': u'O95057'}), PIK3CB({'UP': u'P42338'})	PMC3690480	(C) DIRAS1 and DIRAS2 bind p110beta in a GTP dependent manner.
Complex(DIRAS2(), PIK3CB())	DIRAS2({'UP': u'Q96HU8'}), PIK3CB({'UP': u'P42338'})	PMC3690480	(C) DIRAS1 and DIRAS2 bind p110beta in a GTP dependent manner.
Complex(E2(), wild_type_ERalpha(), NCOA3())	E2({}), wild_type_ERalpha({}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Furthermore, the mutant could still bind to SRC-3 in the presence of E2.
Complex(EGFR(), ERBB3())	EGFR({'UP': u'P00533'}), ERBB3({'UP': u'P21860'})	PMC534114	It has been proposed that the PI-3 kinase is activated in response to EGF stimulation as a consequence of formation of EGFR and ErbB3 heterodimers.
Complex(EGFR(), GAB1())	EGFR({'UP': u'P00533'}), GAB1({'UP': u'Q13480'})	PMC534114	Although the role of the Shp2 protein in the control of EGFR and Gab1 interactions is not well understood, several studies have suggested that Gab1 associated Shp2 may influence EGF induced PI-3 kinase signaling.
Complex(EGFR(), GAB1())	EGFR({'UP': u'P00533'}), GAB1({'UP': u'Q13480'})	PMC534114	Although the role of the Shp2 protein in the control of EGFR and Gab1 interactions is not well understood, several studies have suggested that Gab1 associated Shp2 may influence EGF induced PI-3 kinase signaling.
Complex(EG_mutant(), NCOA3())	EG_mutant({}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	In contrast, a weaker interaction between the EG mutant and SRC-3 was noted.
Complex(ERalpha_mutants(), NCOA3())	ERalpha_mutants({}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	As predicted, the E2 induced interaction between these ERalpha mutants and SRC-3 was greatly reduced or totally abolished in comparison to the positive control (lanes 1 and 2, row 2).
Complex(GAB1(), CBFA2T2())	GAB1({'UP': u'Q13480'}), CBFA2T2({'UP': u'O43439'})	PMC534114	However there have been several reports suggesting that Shp2 may specifically de-phosphorylate the tyrosine phosphorylation sites on Gab1 that bind to p85, thus terminating recruitment of PI-3 kinase and EGF induced activation of the PI-3 kinase pathway [-].
Complex(GAB1(), CBFA2T2())	GAB1({'UP': u'Q13480'}), CBFA2T2({'UP': u'O43439'})	PMC534114	However there have been several reports suggesting that Shp2 may specifically de-phosphorylate the tyrosine phosphorylation sites on Gab1 that bind to p85, thus terminating recruitment of PI-3 kinase and EGF induced activation of the PI-3 kinase pathway [-].
Complex(GAB1(), CBFA2T2())	GAB1({'UP': u'Q13480'}), CBFA2T2({'UP': u'O43439'})	PMC534114	As has been demonstrated previously, wild type Gab1 readily coimmunoprecipitated p85 following EGF treatment, while the Gab1F446/472/589 mutant protein failed to show an association with p85, confirming that the Gab1F446/472/589 protein is deficient in p85 binding.
Complex(GAB1(), CBFA2T2())	GAB1({'UP': u'Q13480'}), CBFA2T2({'UP': u'O43439'})	PMC534114	Using this approach we demonstrated a strict requirement for association between Gab1 and p85 in EGF induced PI-3 kinase activation, suggesting that Gab1 indeed provides an essential link between the EGFR and PI-3 kinase.
Complex(GAB1(), EGFR())	GAB1({'UP': u'Q13480'}), EGFR({'UP': u'P00533'})	PMC534114	While there have been reports that Gab1 binds directly to the EGFR via an 83-amino acid stretch termed the Met-binding-domain or MBD, the majority of Gab1 is believed to be indirectly associated with the EGFR via the adaptor protein Grb2, which binds to a proline rich region on Gab1 via its C-terminal SH3 domain [-].
Complex(GAB1(), PTPN11())	GAB1({'UP': u'Q13480'}), PTPN11({'UP': u'Q06124'})	PMC534114	It was reported that treatment of cells with PI-3 kinase inhibitors or with the phosphatidylinositol (3,4,5) triphosphate (PIP3) phosphatase PTEN interferes with the association between Gab1 and Shp2 in response to EGF treatment, suggesting PI-3 kinase may be required for Shp2 recruitment of Gab1 following EGF stimulation.
Complex(GAB1(), PTPN11())	GAB1({'UP': u'Q13480'}), PTPN11({'UP': u'Q06124'})	PMC534114	The basal interaction we observed between Gab1 and Shp2 in the absence of EGF stimulation is absent in the Gab1F627 and 659 mutant, even following prolonged exposures of the western blot.
Complex(GAB1(), PTPN11())	GAB1({'UP': u'Q13480'}), PTPN11({'UP': u'Q06124'})	PMC534114	Immunoprecipitation of cell lysates with anti-Gab1 antibodies followed by immunoblotting with anti-Shp2 antibodies demonstrates that wild type Gab1 forms a complex with Shp2 following EGF treatment, while the Gab1F627 and 659 mutant proteins fail to show an association with Shp2 thus confirming that phosphorylation of Tyr627 and 659 is required for Shp2 binding (Fig).
Complex(GAB1(), PTPN11())	GAB1({'UP': u'Q13480'}), PTPN11({'UP': u'Q06124'})	PMC534114	We further demonstrated that the Gab1 and Shp2 complex is responsible for the negative regulation of the strength and duration of PI-3 kinase and Akt signaling in response to EGF previously observed in Shp2 -/ - cells.
Complex(GTPase(), PIK3CB())	GTPase({}), PIK3CB({'UP': u'P42338'})	PMC3690480	Importantly, RAC1, CDC42, RHOG, and RHOA preparations bound similar amounts of GTP, indicating proper folding and functionality (E, right lower graph), and a RAC1 I33D mutant showed reduced binding to p110beta (E), confirming a key role of this residue in GTPase binding to p110beta.
Complex(Gbetagamma(), ELMO1())	Gbetagamma({}), ELMO1({'UP': u'Q92556'})	PMC3690480	At present, we can not distinguish between a model in which one Gbetagamma protein heterodimer binds directly to both Elmo1 and p110beta simultaneously and one in which Elmo and p110beta are engaged by two different Gbetagamma protein heterodimers (as shown in F).
Complex(Gbetagamma(), PIK3CB())	Gbetagamma({}), PIK3CB({'UP': u'P42338'})	PMC3690480	The residual p110beta activity in p110beta-RBD-DM MEFs argues for a second, RBD independent activation route, for which direct binding of Gbetagamma to p110beta is the most obvious candidate.
Complex(Gbetagamma(), PIK3CB())	Gbetagamma({}), PIK3CB({'UP': u'P42338'})	PMC3690480	A puzzling question is whether a cooperative effect of RBD interactor and Gbetagamma binding to p110beta can suffice to fully activate p110beta, or if additional phosphotyrosine input is required to overcome the strong inhibition of lipid kinase activity imposed by p85.
Complex(Gbetagamma(), PIK3CB())	Gbetagamma({}), PIK3CB({'UP': u'P42338'})	PMC3690480	At present, we can not distinguish between a model in which one Gbetagamma protein heterodimer binds directly to both Elmo1 and p110beta simultaneously and one in which Elmo and p110beta are engaged by two different Gbetagamma protein heterodimers (as shown in F).
Complex(Gbetagamma(), PIK3CB())	Gbetagamma({}), PIK3CB({'UP': u'P42338'})	PMC3690480	The direct route involves Gbetagamma interaction with p110beta, whereas the indirect route goes through stimulation of RAC via Dock180 and Elmo1, possibly also recruited through Gbetagamma (see F).
Complex(NCOA3(), ERalpha_LBD())	NCOA3({'UP': u'Q9Y6Q9'}), ERalpha_LBD({})	PMC1234335	The SRC-3-AAA mutant has two amino acid substitutions within each of its three NR boxes, such that the LXXLL motifs are mutated to LXXAA (36); this abolishes the ligand dependent binding between SRC-3 and the ERalpha LBD (10, 12, 21, 40).
Complex(NCOA3(), esr1())	NCOA3({'UP': u'Q9Y6Q9'}), esr1({'UP': u'P81559'})	PMC1234335	Together these data demonstrate that E2 induced SRC-3 phosphorylation is dependent on a direct interaction between SRC-3 and ERalpha and can occur outside of the nucleus.
Complex(NCOA3(), esr1())	NCOA3({'UP': u'Q9Y6Q9'}), esr1({'UP': u'P81559'})	PMC1234335	Mutations that disrupt the formation of the coactivator binding groove of ERalpha or mutations in the LXXLL motifs of SRC-3 abolish interaction between SRC-3 and ERalpha and thus coactivation of ERalpha (38).
Complex(NCOA3(), esr1())	NCOA3({'UP': u'Q9Y6Q9'}), esr1({'UP': u'P81559'})	PMC1234335	These data indicated that an intact coactivator binding groove within the LBD is essential for E2 induced SRC-3 phosphorylation and imply that a direct interaction between SRC-3 and ERalpha is necessary.
Complex(NCOA3(), esr1())	NCOA3({'UP': u'Q9Y6Q9'}), esr1({'UP': u'P81559'})	PMC1234335	Here we report that E2 induced SRC-3 phosphorylation occurs within minutes and requires a direct interaction between SRC-3 and ERalpha but does not require nuclear localization or the DNA binding activity of ERalpha.
Complex(NCOA3(), esr1())	NCOA3({'UP': u'Q9Y6Q9'}), esr1({'UP': u'P81559'})	PMC1234335	Here we show that E2 induced SRC-3 phosphorylation requires a direct interaction between SRC-3 and ERalpha but does not require DNA binding and nuclear localization of ERalpha, indicating a " nongenomic " action of this receptor.
Complex(Non_beta_isoforms(), RAS())	Non_beta_isoforms({}), RAS({'IP': u'IPR020849'})	PMC3690480	(D) Non beta isoforms bind to RAS proteins and a number of closely related RFGs.
Complex(PIK3CA(), PIK3CG())	PIK3CA({'UP': u'P42336'}), PIK3CG({'UP': u'P48736'})	PMC3690480	Similar affinities have been reported for the RAS-p110alpha and RAS-p110gamma interactions, indicating that RAC1 and CDC42 areplausible RBD interactors of p110beta.
Complex(PIK3CB(), CBFA2T2())	PIK3CB({'UP': u'P42338'}), CBFA2T2({'UP': u'O43439'})	PMC3690480	To identify RBD interactors of p110beta, we probed all 34 murine members of the RAS subfamily of small GTPases (RFGs) for binding to p110beta and p85 (C).
Complex(PIK3CB(), CBFA2T2())	PIK3CB({'UP': u'P42338'}), CBFA2T2({'UP': u'O43439'})	PMC3690480	Lipid kinase assay assessing basal activities of purified recombinant p110beta and p85 complexes (n = 3; mean with SEM).
Complex(PIK3CB(), CBFA2T2())	PIK3CB({'UP': u'P42338'}), CBFA2T2({'UP': u'O43439'})	PMC3690480	GST pulldown assay assessing binding of purified recombinant p110beta and p85 complexes to immobilized, GDP - / GTPgammaS loaded DIRAS1.
Complex(PIK3CB(), CBFA2T2())	PIK3CB({'UP': u'P42338'}), CBFA2T2({'UP': u'O43439'})	PMC3690480	Purified recombinant wild-type RAC1 and a RAC1 I33D mutant were compared for GTP dependent binding to purified recombinant p110beta and p85 (50nM).
Complex(PIK3CB(), CDC42())	PIK3CB({'UP': u'P42338'}), CDC42({'UP': u'P60953'})	PMC3690480	Surprisingly, p110beta bound to both RAC1 and CDC42 in a GTP dependent manner.
Complex(PIK3CB(), CDC42())	PIK3CB({'UP': u'P42338'}), CDC42({'UP': u'P60953'})	PMC3690480	(F) Binding of p110beta to RAC1 and CDC42 is isoform specific.
Complex(PIK3CB(), DIRAS())	PIK3CB({'UP': u'P42338'}), DIRAS({})	PMC3690480	This substitution is relevant to PI3K binding because an HRAS D33I mutant showed attenuated binding to p110alpha and DIRAS1-I37D showed reduced binding to p110beta, even though exchange of this residue did not enable RAS binding to p110beta or DIRAS binding to p110alpha (A), pointing to additional, G2-box-independent determinants of PI3K isoform specificity.
Complex(PIK3CB(), DIRAS1())	PIK3CB({'UP': u'P42338'}), DIRAS1({'UP': u'O95057'})	PMC3690480	Instead, p110beta exclusively bound to the more distantly related DIRAS1 and DIRAS2 proteins in a GTP dependent manner (C).
Complex(PIK3CB(), Deltap85())	PIK3CB({'UP': u'P42338'}), Deltap85({})	PMC3690480	To test whether the BCR homology domain (BHD) on p85, which had previously been shown to bind RAC and CDC42, is required for RAC and CDC42 binding to p110beta, we truncated p85 (Deltap85 schematic in C) and probed for binding of p110beta and Deltap85 to RAC1 and CDC42 invitro.
Complex(PIK3CB(), PIK3CB())	PIK3CB({'UP': u'P42338'}), PIK3CB({'UP': u'P42338'})	PMC3690480	Surprisingly, p110beta bound to both RAC1 and CDC42 in a GTP dependent manner.
Complex(PIK3CB(), RAB5A())	PIK3CB({'UP': u'P42338'}), RAB5A({'UP': u'P20339'})	PMC3690480	In contrast, p110beta bound to none of the RAS proteins, but did bind to RAB5, a previously identified GTPase interactor of p110beta.
Complex(PIK3CB(), RAC1())	PIK3CB({'UP': u'P42338'}), RAC1({'UP': u'P63000'})	PMC3690480	Surprisingly, p110beta bound to both RAC1 and CDC42 in a GTP dependent manner.
Complex(PIK3CB(), RAC1())	PIK3CB({'UP': u'P42338'}), RAC1({'UP': u'P63000'})	PMC3690480	(F) Binding of p110beta to RAC1 and CDC42 is isoform specific.
Complex(PIK3CB(), RAC1())	PIK3CB({'UP': u'P42338'}), RAC1({'UP': u'P63000'})	PMC3690480	(C) The N terminus of p85 is not required for p110beta binding to RAC1 and CDC42.
Complex(PIK3CB(), RAC1())	PIK3CB({'UP': u'P42338'}), RAC1({'UP': u'P63000'})	PMC3690480	Amino acid alignment of type I PI3K RBDs with secondary structure elements of p110beta (H, helix; E, beta sheet) and color coding to illustrate effect of residue mutation on p110beta binding to RAC1 and CDC42.
Complex(PIK3CB(), RAC1())	PIK3CB({'UP': u'P42338'}), RAC1({'UP': u'P63000'})	PMC3690480	(D) Single RBD point mutations disrupt p110beta binding to RAC1 and CDC42.
Complex(PIK3CB(), RAS())	PIK3CB({'UP': u'P42338'}), RAS({'IP': u'IPR020849'})	PMC3690480	That p110beta proved unable to physically and functionally interact with RAS is unexpected given the presence of a moderately conserved PI3K-type RBD in all four type I PI3K p110 catalytic subunits.
Complex(PIK3CB(), RAS())	PIK3CB({'UP': u'P42338'}), RAS({'IP': u'IPR020849'})	PMC3690480	RAC and CDC42 Are Interactors of the p110beta RAS Binding Domain
Complex(PIK3CB(), RAS())	PIK3CB({'UP': u'P42338'}), RAS({'IP': u'IPR020849'})	PMC3690480	RAC and CDC42 Are Interactors of the p110beta RAS Binding Domain, Related to
Complex(PIK3CB(), RHO())	PIK3CB({'UP': u'P42338'}), RHO({'IP': u'IPR003578'})	PMC3690480	Surprisingly, p110beta bound to both RAC1 and CDC42 in a GTP dependent manner.
Complex(PLX(), RAF1())	PLX({'UP': u'P81565'}), RAF1({'UP': u'P04049'})	PMC3178447	To test whether direct binding of PLX to CRAF is required for induction of signaling, we generated a catC carrying a mutation at the gatekeeper position (T421) in the kinase domain (mutations used and their properties are in).
Complex(PLX(), RAF1())	PLX({'UP': u'P81565'}), RAF1({'UP': u'P04049'})	PMC3178447	The data suggest that binding of PLX to CRAF induces activation of the enzyme and, subsequently, ERK signaling.
Complex(PTPN11(), GAB1())	PTPN11({'UP': u'Q06124'}), GAB1({'UP': u'Q13480'})	PMC534114	We utilized the Gab1 proteins deficient in Shp2 binding to assay more directly the role of the Shp2 and Gab1 complex in mediating activation of PI-3 kinase and Akt in response to EGF stimulation.
Complex(RAB5A(), PIK3CB(), Cacna1d())	RAB5A({'UP': u'P20339'}), PIK3CB({'UP': u'P42338'}), Cacna1d({'UP': u'P27732'})	PMC3690480	The RAB5 binding site on p110beta remains to be determined, yet several findings argue against RAB5 binding to p110beta through the RBD : (1) binding of RAB5 is entirely unaffected by p110beta RBD mutations (C); (2) RAB5 does not appear to stimulate p110beta (C,; (3) the affinity between RAB5 and p110beta in solution appears to be significantly higher (data not shown) than for typical PI3K RBD interactors, suggesting a more stable interaction, allowing to effectively localize p110beta to RAB5-positve subcellular compartments.
Complex(RAB5A(), PIK3CB(), Cacna1d())	RAB5A({'UP': u'P20339'}), PIK3CB({'UP': u'P42338'}), Cacna1d({'UP': u'P27732'})	PMC3690480	The RAB5 binding site on p110beta remains to be determined, yet several findings argue against RAB5 binding to p110beta through the RBD : (1) binding of RAB5 is entirely unaffected by p110beta RBD mutations (C); (2) RAB5 does not appear to stimulate p110beta (C,; (3) the affinity between RAB5 and p110beta in solution appears to be significantly higher (data not shown) than for typical PI3K RBD interactors, suggesting a more stable interaction, allowing to effectively localize p110beta to RAB5-positve subcellular compartments.
Complex(RAC1(), CDC42())	RAC1({'UP': u'P63000'}), CDC42({'UP': u'P60953'})	PMC3690480	To further corroborate these findings, we generated 43 single point mutations covering 37 residues across the p110beta RBD and assayed these mutants for binding to RAC1 and CDC42 (D, A, and S3B).
Complex(RAC1(), CDC42())	RAC1({'UP': u'P63000'}), CDC42({'UP': u'P60953'})	PMC3690480	We did not study monomeric p85, which has not been found in living cells, but our biochemical data strongly argue against an involvement of p85 in the RAC and CDC42-p 110beta interaction, because (1) RAC1 and CDC42 do not interact with p110alpha and p85 or p110delta and p85, (2) RAC1 and CDC42 bind normally to p110beta in the absence of the p85 BH domain, and (3) RBD point mutations abrogate RAC1 and CDC42 binding to p110beta in complex with full-length p85.
Complex(RAC1(), CDC42())	RAC1({'UP': u'P63000'}), CDC42({'UP': u'P60953'})	PMC3690480	Point mutations made are listed along with their impact on binding to RAC1 and CDC42 (+, no effect on binding;(+), reduced binding; -, complete or near complete loss of binding; unst., unstable protein).
Complex(RAC1(), GTP())	RAC1({'UP': u'P63000'}), GTP({})	PMC3690480	Importantly, RAC1, CDC42, RHOG, and RHOA preparations bound similar amounts of GTP, indicating proper folding and functionality (E, right lower graph), and a RAC1 I33D mutant showed reduced binding to p110beta (E), confirming a key role of this residue in GTPase binding to p110beta.
Complex(RAC1(), PIK3CB())	RAC1({'UP': u'P63000'}), PIK3CB({'UP': u'P42338'})	PMC3690480	Taken together, these data show that the RHO family GTPases RAC1 and CDC42 bind to p110beta in an isoform specific manner and potently and directly stimulate its lipid kinase activity.
Complex(RAC1(), PIK3CB())	RAC1({'UP': u'P63000'}), PIK3CB({'UP': u'P42338'})	PMC3690480	We did not study monomeric p85, which has not been found in living cells, but our biochemical data strongly argue against an involvement of p85 in the RAC and CDC42-p 110beta interaction, because (1) RAC1 and CDC42 do not interact with p110alpha and p85 or p110delta and p85, (2) RAC1 and CDC42 bind normally to p110beta in the absence of the p85 BH domain, and (3) RBD point mutations abrogate RAC1 and CDC42 binding to p110beta in complex with full-length p85.
Complex(RAC1(), PIK3CB())	RAC1({'UP': u'P63000'}), PIK3CB({'UP': u'P42338'})	PMC3690480	(D) RAC1 and CDC42 bind p110beta in a GTP dependent manner.
Complex(RAC1(), PIK3CB(), Cacna1d())	RAC1({'UP': u'P63000'}), PIK3CB({'UP': u'P42338'}), Cacna1d({'UP': u'P27732'})	PMC3690480	* Unlike p110alpha, p110gamma, and p110delta PI3K isoforms, RAS is unable to interact with p110beta * The RHO family GTPases RAC1 and CDC42 directly bind and activate p110beta via its RBD * GPCRs couple to PI3K via Dock180 and Elmo1-mediated RAC activation and binding to p110beta * Mice with RBD mutant p110beta are resistant to experimental lung fibrosis
Complex(RAC1(), PIK3CB(), Cacna1d())	RAC1({'UP': u'P63000'}), PIK3CB({'UP': u'P42338'}), Cacna1d({'UP': u'P27732'})	PMC3690480	* Unlike p110alpha, p110gamma, and p110delta PI3K isoforms, RAS is unable to interact with p110beta * The RHO family GTPases RAC1 and CDC42 directly bind and activate p110beta via its RBD * GPCRs couple to PI3K via Dock180 and Elmo1-mediated RAC activation and binding to p110beta * Mice with RBD mutant p110beta are resistant to experimental lung fibrosis
Complex(RAC1_GTPgammaS(), Deltap85())	RAC1_GTPgammaS({}), Deltap85({})	PMC3690480	In solution, RAC1.GTPgammaS bound to p110beta and Deltap85 with a molar ratio close to 1 and an average Kd of 1.42 muM, whereas the affinity measured for CDC42.GTPgammaS was 3.1 muM (E and 3F).
Complex(RAC1_GTPgammaS(), PIK3CB())	RAC1_GTPgammaS({}), PIK3CB({'UP': u'P42338'})	PMC3690480	In solution, RAC1.GTPgammaS bound to p110beta and Deltap85 with a molar ratio close to 1 and an average Kd of 1.42 muM, whereas the affinity measured for CDC42.GTPgammaS was 3.1 muM (E and 3F).
Complex(RAS(), Drosophila_type_I_PI3K())	RAS({'IP': u'IPR020849'}), Drosophila_type_I_PI3K({})	PMC3690480	In addition, RBD mutations have been used to demonstrate that input of RAS binding to the single Drosophila type I PI3K is critical in insulin-pathway-controlled developmental growth and that RAS binding is required for PI3K activation by chemoattractants in Dictyostelium.
Complex(RAS(), PI3K_isoforms())	RAS({'IP': u'IPR020849'}), PI3K_isoforms({})	PMC3690480	RAS proteins bind and activate multiple PI3K isoforms.
Complex(RAS(), PI3K_isoforms())	RAS({'IP': u'IPR020849'}), PI3K_isoforms({})	PMC3690480	RAS proteins bind and activate multiple PI3K isoforms.
Complex(RAS(), PIK3CB())	RAS({'IP': u'IPR020849'}), PIK3CB({'UP': u'P42338'})	PMC3690480	This substitution is relevant to PI3K binding because an HRAS D33I mutant showed attenuated binding to p110alpha and DIRAS1-I37D showed reduced binding to p110beta, even though exchange of this residue did not enable RAS binding to p110beta or DIRAS binding to p110alpha (A), pointing to additional, G2-box-independent determinants of PI3K isoform specificity.
Complex(RAS(), PIK3CG())	RAS({'IP': u'IPR020849'}), PIK3CG({'UP': u'P48736'})	PMC3690480	The 3D structure of RAS bound to p110gamma has been determined, and RAS has been shown to activate the lipid kinase activity of p110gamma cooperatively with input from Gbetagamma subunits via the regulatory p101 subunit.
Complex(RAS(), PIK3CG())	RAS({'IP': u'IPR020849'}), PIK3CG({'UP': u'P48736'})	PMC3690480	The direct binding of RAS to p110gamma has also been studied in detail.
Complex(RHO(), PIK3CB())	RHO({'IP': u'IPR003578'}), PIK3CB({'UP': u'P42338'})	PMC3690480	Taken together, these data show that the RHO family GTPases RAC1 and CDC42 bind to p110beta in an isoform specific manner and potently and directly stimulate its lipid kinase activity.
Complex(RHOA(), GTP())	RHOA({'UP': u'P61586'}), GTP({})	PMC3690480	Importantly, RAC1, CDC42, RHOG, and RHOA preparations bound similar amounts of GTP, indicating proper folding and functionality (E, right lower graph), and a RAC1 I33D mutant showed reduced binding to p110beta (E), confirming a key role of this residue in GTPase binding to p110beta.
Complex(RHOG(), GTP())	RHOG({'UP': u'P84095'}), GTP({})	PMC3690480	Importantly, RAC1, CDC42, RHOG, and RHOA preparations bound similar amounts of GTP, indicating proper folding and functionality (E, right lower graph), and a RAC1 I33D mutant showed reduced binding to p110beta (E), confirming a key role of this residue in GTPase binding to p110beta.
Complex(RHOG(), RHOA())	RHOG({'UP': u'P84095'}), RHOA({'UP': u'P61586'})	PMC3690480	Weaker binding to RHOG and minimal binding to RHOA was also observed (E).
Complex(SRC(), their_receptor())	SRC({}), their_receptor({})	PMC1234335	SRC family members contain several LXXLL motifs located in their receptor interacting domains that mediate their direct binding to the LBD of nuclear receptors such as ERalpha.
Complex(esr1(), NCOA3())	esr1({'UP': u'P81559'}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Since SERMs do not promote interaction between SRC coactivators and ER in HEK293T (data not shown) and other cell lines (23, 48), the data are consistent with a requirement for a direct binding between ER and SRC-3 for induction of coactivator phosphorylation.
Complex(esr1(), NCOA3())	esr1({'UP': u'P81559'}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	The results above demonstrated that ER is required for E2 induced SRC-3 phosphorylation and implied that an interaction, either direct or indirect, between ER and SRC-3 is required.
Complex(esr1(), pelp1())	esr1({'UP': u'P81559'}), pelp1({'UP': u'Q58HI1'})	PMC1234335	For example, E2 can induce a rapid and transient activation of the Src and Erk phosphorylation cascade through the association between cytoplasm localized ERalpha and MNAR (modulator of nongenomic activity of ER) (73).
Complex(p110_subunit(), CBFA2T2())	p110_subunit({}), CBFA2T2({'UP': u'O43439'})	PMC3690480	Expression levels of p110beta, p110alpha, and p85 were indistinguishable among the genotypes (D), and the stoichiometry of p110 subunit binding to p85 was undisturbed (E).
Complex(p110beta_RBD_DM(), CBFA2T2())	p110beta_RBD_DM({}), CBFA2T2({'UP': u'O43439'})	PMC3690480	Purified recombinant wild-type p110beta and p85 bound to RAC1 and CDC42 in a concentration dependent manner, whereas p110beta-RBD-DM and p85 complexes showed no binding (A).
Complex(recombinant_p110(), CBFA2T2())	recombinant_p110({}), CBFA2T2({'UP': u'O43439'})	PMC3690480	(C) Panel of representative ITC experiments investigating the thermodynamics of the interaction between indicated GTPgammaS loaded small GTPases and recombinant p110 and p85 complexes in solution.
Complex(small_GTPases(), PI3K())	small_GTPases({}), PI3K({'UP': u'P42347'})	PMC3690480	A very recent study using microscopy based assays in transfected cells revisited the interaction of small GTPases and PI3K, confirming that both active RAS and RHO family GTPases can activate PI3K in living cells.
Phosphorylation(EGF(), EGF(), Phosphorylation, None)	EGF({'UP': u'P01133'}), EGF({'UP': u'P01133'})	PMC534114	Gab1F627 and 659 becomes tyrosine phosphorylated in response to EGF treatment to levels approximately 1.5-fold higher than Gab1 as determined by densitometry, while Gab1F446/472/589 / 627 and 659 does not show EGF induced tyrosine phosphorylation in this assay.
Phosphorylation(EGF(), Erk(), Phosphorylation, None)	EGF({'UP': u'P01133'}), Erk({'IP': u'IPR008349'})	PMC4345513	Sustained Erk phosphorylation by nerve growth factor (NGF) induces differentiation, while transient Erk phosphorylation by epidermal growth factor (EGF) stimulates cell proliferation in PC12 cells.
Phosphorylation(EGF(), GAB1(), Phosphorylation, None)	EGF({'UP': u'P01133'}), GAB1({'UP': u'Q13480'})	PMC534114	EGF stimulation leads to tyrosine phosphorylation of Gab1 enabling recruitment and activation of PI-3 kinase by the three canonical pYXXM motifs on Gab1.
Phosphorylation(EGF(), GAB1(), PhosphorylationTyrosine, None)	EGF({'UP': u'P01133'}), GAB1({'UP': u'Q13480'})	PMC534114	This result suggests that Gab1 may be a substrate of Shp2, and that blocking Shp2 binding thereby increases EGF induced Gab1 tyrosine phosphorylation.
Phosphorylation(EG_ERalpha_DBD_mutants(), NCOA3(), Phosphorylation, None)	EG_ERalpha_DBD_mutants({}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	However, both of the CC and EG ERalpha DBD mutants induced SRC-3 phosphorylation, represented by sites S505, S543, and S867.
Phosphorylation(ERalpha_mutant(), NCOA3(), Phosphorylation, None)	ERalpha_mutant({}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	A transcriptionally inactive ERalpha mutant which localizes to the cytoplasm supports E2 induced SRC-3 phosphorylation.
Phosphorylation(ERalpha_single_mutants(), NCOA3(), Phosphorylation, None)	ERalpha_single_mutants({}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Fig. 5B,5 B, the ERalpha single mutants (K, V, or L) were severely compromised in their ability to support E2 induced SRC-3 phosphorylation (lanes 5 to 10, row 1), while the triple mutant (KVL) was unable to induce any phosphorylation of SRC-3 (lanes 3 and 4, row 1).
Phosphorylation(FGF2(), MAPK3(), Phosphorylation, None)	FGF2({'UP': u'P09038'}), MAPK3({'UP': u'P27361'})	PMC4345513	Here, we show that overexpression of active H-Ras (H-RasG12R) in NIH3T3 fibroblasts impaired FGF2 induced Erk1 and 2 phosphorylation, as compared to wild-type cells.
Phosphorylation(HER2(), NCOA3(), Phosphorylation, None)	HER2({'UP': u'Q75D84'}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	For example, in HER2 overexpressing breast cancers, SRC-3 phosphorylation induced by HER2 signaling may facilitate coactivator function under conditions of low E2 or tamoxifen exposure and thereby contribute to endocrine resistance (4, 49, 60).
Phosphorylation(PLX(), ERK(), Phosphorylation, None)	PLX({'UP': u'P81565'}), ERK({'IP': u'IPR008349'})	PMC3178447	PLX induced pronounced phosphorylation of MEK and ERK in wild-type MEFs and BRAF (-/-) MEFs.
Phosphorylation(PLX(), ERK(), Phosphorylation, None)	PLX({'UP': u'P81565'}), ERK({'IP': u'IPR008349'})	PMC3178447	In 293H cells expressing the catalytic domain of CRAF (catC), PLX caused dramatic induction of MEK and ERK phosphorylation.
Phosphorylation(PLX(), MEK(), Phosphorylation, None)	PLX({'UP': u'P81565'}), MEK({})	PMC3178447	PLX induced pronounced phosphorylation of MEK and ERK in wild-type MEFs and BRAF (-/-) MEFs.
Phosphorylation(PLX(), MEK(), Phosphorylation, None)	PLX({'UP': u'P81565'}), MEK({})	PMC3178447	In 293H cells expressing the catalytic domain of CRAF (catC), PLX caused dramatic induction of MEK and ERK phosphorylation.
Phosphorylation(PLX(), RAF1(), PhosphorylationSerine, 621)	PLX({'UP': u'P81565'}), RAF1({'UP': u'P04049'})	PMC3178447	Phosphorylation of CRAF at S338 and S621 has been correlated with its activation.
Phosphorylation(PLX4720(), ERK(), Phosphorylation, None)	PLX4720({}), ERK({'IP': u'IPR008349'})	PMC3178447	In 293H cells, induction of MEK and ERK phosphorylation by either PLX4032 or PLX4720 was barely detectable (PLX will refer to data obtained with both compounds).
Phosphorylation(PLX4720(), MEK(), Phosphorylation, None)	PLX4720({}), MEK({})	PMC3178447	In 293H cells, induction of MEK and ERK phosphorylation by either PLX4032 or PLX4720 was barely detectable (PLX will refer to data obtained with both compounds).
Phosphorylation(SERMs(), NCOA3(), Phosphorylation, None)	SERMs({}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	In order to investigate whether selective estrogen receptor modulators (SERMs) such as 4HT and Ral and pure antagonists such as ICI 182,780 (ICI) can induce SRC-3 phosphorylation, drug treatment (10 nM, 1 h) was performed in HEK293T cells cotransfected with plasmids for Flag tagged SRC-3 and ERalpha 3B) or ERbeta.3 C).
Phosphorylation(TNF(), NCOA3(), Phosphorylation, None)	TNF({'UP': u'Q9BEA1'}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Previously, we reported that TNF-alpha induces phosphorylation of SRC-3 in an ER independent fashion and that the patterns of phosphorylated residues induced by TNF-alpha and E2 overlapped but were not identical (75).
Phosphorylation(V5_catCS428C(), MEK(), Phosphorylation, None)	V5_catCS428C({}), MEK({})	PMC3178447	V5-catCS428C / D486N is deficient in catalytic activity; it can bind to the inhibitor (JAB34) but can not phosphorylate MEK, while FLAG-catC is catalytically active, but can not bind JAB34.
Phosphorylation(albA2(), NCOA3(), Phosphorylation, None)	albA2({'UP': u'O28323'}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Interestingly, this ERalpha AF-1 phosphorylation mutant could still induce SRC-3 phosphorylation, at a level comparable to the wild-type ERalpha,4 C), suggesting that phosphorylation of ERalpha is not a prerequisite for promoting SRC-3 phosphorylation.
Phosphorylation(chuk(), SRC(), Phosphorylation, None)	chuk({'UP': u'Q6GM53'}), SRC({})	PMC1234335	Indeed, the kinases ERK1 and 2, p38 MAPK, protein kinase A, and IKKalpha can phosphorylate both ER and SRC family members (7, 24, 29, 35, 50, 56, 75).
Phosphorylation(chuk(), esr1(), Phosphorylation, None)	chuk({'UP': u'Q6GM53'}), esr1({'UP': u'P81559'})	PMC1234335	Indeed, the kinases ERK1 and 2, p38 MAPK, protein kinase A, and IKKalpha can phosphorylate both ER and SRC family members (7, 24, 29, 35, 50, 56, 75).
Phosphorylation(dexamethasone(), NCOA3(), Phosphorylation, None)	dexamethasone({'CHEBI': u'41873'}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	As in the case of PR-B, dexamethasone did not induce SRC-3 phosphorylation in cells expressing the glucocorticoid receptor (data not shown).
Phosphorylation(esr1(), NCOA3(), Phosphorylation, None)	esr1({'UP': u'P81559'}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Our data provide the first indication of an E2 induced assembly of an extranuclear SRC-3- and ERalpha containing complex prior to promoter binding, which is essential for E2 induced SRC-3 phosphorylation and thus for its biological functions.
Phosphorylation(esr1(), NCOA3(), Phosphorylation, None)	esr1({'UP': u'P81559'}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	ERalpha DNA binding activity is not required for E2 induced SRC-3 phosphorylation.
Phosphorylation(esr2(), NCOA3(), PhosphorylationSerine, 505)	esr2({'UP': u'O13012'}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Similarly, an ERbeta truncation mutant, 143C (aa 143 to 530), lacking AF-1, supported only minimal E2 induced SRC-3 phosphorylation at S505 and S543 but not at other sites as represented by T24 and S867.4 B).
Phosphorylation(esr2(), NCOA3(), PhosphorylationSerine, 543)	esr2({'UP': u'O13012'}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Similarly, an ERbeta truncation mutant, 143C (aa 143 to 530), lacking AF-1, supported only minimal E2 induced SRC-3 phosphorylation at S505 and S543 but not at other sites as represented by T24 and S867.4 B).
Phosphorylation(estrogen(), NCOA3(), Phosphorylation, None)	estrogen({'HMDB': u'01926'}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	This dichotomy suggests that the extensive phosphorylation of SRC-3 induced by estrogen and androgen may relate to the well-known growth promoting actions of their cognate receptors.
Phosphorylation(growth_factor(), Erk(), Phosphorylation, None)	growth_factor({'UP': u'P08441'}), Erk({'IP': u'IPR008349'})	PMC4345513	Sustained Erk phosphorylation by nerve growth factor (NGF) induces differentiation, while transient Erk phosphorylation by epidermal growth factor (EGF) stimulates cell proliferation in PC12 cells.
Phosphorylation(impact(), NCOA3(), Phosphorylation, None)	impact({'UP': u'Q9W625'}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	In order to investigate whether this surface is essential for E2 induced SRC-3 phosphorylation, several mutations which disrupt the direct interaction of ERalpha with coactivator were examined for their ability to impact E2 induction of SRC-3 phosphorylation in HEK293T cells.
Phosphorylation(insulin(), Akt1(), Phosphorylation, None)	insulin({'IP': u'IPR004825'}), Akt1({'UP': u'P31750'})	PMC3690480	Similarly, EHT1864, a direct inhibitor of RAC but not CDC42 activation, dose-dependently inhibited AKT phosphorylation induced by LPA and S1P (E), but not EGF, PDGF, or insulin (F).
Phosphorylation(insulin(), Akt1(), Phosphorylation, None)	insulin({'IP': u'IPR004825'}), Akt1({'UP': u'P31750'})	PMC3690480	In contrast, knockdown of the Dock family RAC-GEF Dock180 or its adaptor protein Elmo1 interfered with AKT phosphorylation induced by LPA and S1P (B and B), but not by EGF, PDGF, and insulin (C).
Phosphorylation(nr3c1(), NCOA3(), Phosphorylation, None)	nr3c1({'UP': u'P49844'}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Conceivably, PR or GR and their cognate ligands may induce phosphorylation of SRC-3 at sites distinct from those known to be phosphorylated in response to ER or AR ligands.
Phosphorylation(ral(), NCOA3(), Phosphorylation, None)	ral({'UP': u'P03703'}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Tamoxifen and ICI 3B) and 4HT and Ral,3 C), unlike E2, did not noticeably induce SRC-3 phosphorylation at sites S505 and S867 in the presence of ERalpha and ERbeta, respectively (lanes 3 and 4, rows 1 and 2).
Phosphorylation(tamoxifen(), NCOA3(), Phosphorylation, None)	tamoxifen({'CHEBI': u'41774'}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Indeed, tamoxifen induces SRC-3 phosphorylation as shown by its mobility shift and phosphatase treatment and serves as an agonist of ER and SRC -3 - dependent transcription in HER2 overexpressing breast cancer cells (60).
Phosphorylation(wild_type_ERalpha(), NCOA3(), Phosphorylation, None)	wild_type_ERalpha({}), NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	As for wild-type ERalpha, the mutant was able to induce SRC-3 phosphorylation at all six sites,7 B), indicating that nuclear localization of ERalpha may not be required for inducing SRC-3 phosphorylation in response to E2.
Phosphorylation(None, Akt1(), Phosphorylation, None)	Akt1({'UP': u'P31750'})	PMC3690480	In p110beta-RBD-DM MEFs, LPA- and S1P induced phosphorylation of AKT was strongly diminished, whereas ERK phosphorylation was undisturbed (A and A).
Phosphorylation(None, Akt1(), Phosphorylation, None)	Akt1({'UP': u'P31750'})	PMC3690480	Also, in time course experiments, AKT phosphorylation was more transient when the p110beta RBD was mutated (B and not shown).
Phosphorylation(None, Akt1(), Phosphorylation, None)	Akt1({'UP': u'P31750'})	PMC3690480	Notably, in p110beta-knockout cells, AKT phosphorylation in response to LPA was completely abolished (C), indicating that the RBD is essential for much but not all p110beta activation downstream of GPCRs.
Phosphorylation(None, Akt1(), Phosphorylation, None)	Akt1({'UP': u'P31750'})	PMC3690480	LPA and S1P dose-dependently induced both AKT and ERK phosphorylation in wild-type cells (A and A).
Phosphorylation(None, Akt1(), Phosphorylation, None)	Akt1({'UP': u'P31750'})	PMC3690480	Transfection of wild-type MEFs with siRNA pools targeting the Dbl family RAC-GEFs Vav1-3, PREX1 and 2, and alpha - / beta-PIX had no clear effect on LPA and S1P-induced AKT phosphorylation (A and A).
Phosphorylation(None, Akt1(), Phosphorylation, None)	Akt1({'UP': u'P31750'})	PMC3690480	(A) LPA induced AKT phosphorylation is attenuated in p110beta-RBD-DM MEFs.
Phosphorylation(None, Akt1(), Phosphorylation, None)	Akt1({'UP': u'P31750'})	PMC3690480	(B) LPA induced AKT phosphorylation is more transient in p110beta-RBD-DM MEFs.
Phosphorylation(None, Akt1(), Phosphorylation, None)	Akt1({'UP': u'P31750'})	PMC3690480	(C) LPA induced AKT phosphorylation is entirely dependent on p110beta.
Phosphorylation(None, Akt1(), Phosphorylation, None)	Akt1({'UP': u'P31750'})	PMC3690480	(D) LPA - / S1P induced AKT phosphorylation requires RAC.
Phosphorylation(None, Akt1(), Phosphorylation, None)	Akt1({'UP': u'P31750'})	PMC3690480	(E) LPA - / S1P induced AKT phosphorylation requires RAC activity.
Phosphorylation(None, Akt1(), Phosphorylation, None)	Akt1({'UP': u'P31750'})	PMC3690480	(B) Dock180 and Elmo1 are essential for LPA induced AKT phosphorylation.
Phosphorylation(None, Akt1(), Phosphorylation, None)	Akt1({'UP': u'P31750'})	PMC3690480	(A) S1P induced AKT phosphorylation is attenuated in p110beta-RBD-DM MEFs.
Phosphorylation(None, Akt1(), Phosphorylation, None)	Akt1({'UP': u'P31750'})	PMC3690480	(B) LPA and S1P-induced phosphorylation of AKT and ERK is sensitive to PTX.
Phosphorylation(None, Akt1(), Phosphorylation, None)	Akt1({'UP': u'P31750'})	PMC3690480	(E) RAC and CDC42 are not required for AKT phosphorylation induced by receptor tyrosine kinase agonists.
Phosphorylation(None, Akt1(), Phosphorylation, None)	Akt1({'UP': u'P31750'})	PMC3690480	(A) siRNA pools targeting Dbl family RAC-GEFs fail to affect S1P induced AKT phosphorylation.
Phosphorylation(None, Akt1(), Phosphorylation, None)	Akt1({'UP': u'P31750'})	PMC3690480	(B) Dock180 and Elmo1 are essential for S1P induced AKT phosphorylation.
Phosphorylation(None, Akt1(), Phosphorylation, None)	Akt1({'UP': u'P31750'})	PMC3690480	(F) Knockdown of Elmo1 but not Elmo2 affects LPA induced AKT phosphorylation.
Phosphorylation(None, Akt1(), Phosphorylation, None)	Akt1({'UP': u'P31750'})	PMC534114	The phosphorylation of AKT in cells expressing Gab1, which shows modest enhancement following treatment with NRG, may be attributed to alternate signaling pathways including those mediated by ErbB2 and ErbB4.
Phosphorylation(None, Akt1(), PhosphorylationTyrosine, None)	Akt1({'UP': u'P31750'})	PMC534114	MEFs derived from Gab1-/- or wild type (WT) embryos were stimulated with EGF and assayed for Gab1 tyrosine phosphorylation, for activation of PI-3 kinase and for Akt stimulation.
Phosphorylation(None, BRAF(), Phosphorylation, None)	BRAF({})	PMC3178447	Phosphorylation and expression of the indicated proteins were assayed by immunoblotting.
Phosphorylation(None, CBFA2T2(), PhosphorylationTyrosine, None)	CBFA2T2({'UP': u'O43439'})	PMC534114	Cell extracts were prepared and analyzed for Gab1 tyrosine phosphorylation, Gab1 co-immunoprecipitation with p85, p85 expression, Gab1 co-immunoprecipitation with Shp2, and Gab1 expression.
Phosphorylation(None, CRAFT421M_mutant(), Phosphorylation, None)	CRAFT421M_mutant({})	PMC3178447	In contrast, it did not affect the phosphorylation of the PLX resistant CRAFT421M mutant.
Phosphorylation(None, CYP37(), Phosphorylation, None)	CYP37({'UP': u'P82869'})	PMC1234335	Indeed, the kinases ERK1 and 2, p38 MAPK, protein kinase A, and IKKalpha can phosphorylate both ER and SRC family members (7, 24, 29, 35, 50, 56, 75).
Phosphorylation(None, EGF(), Phosphorylation, None)	EGF({'UP': u'P01133'})	PMC534114	As shown in Figure, the endogenous Gab1 present in WT MEFs is tyrosine phosphorylated in response to EGF treatment.
Phosphorylation(None, EGF(), Phosphorylation, None)	EGF({'UP': u'P01133'})	PMC534114	We first assayed the cells for Gab1 expression, and for the ability of the mutant Gab1F446/472/589 protein to become tyrosine phosphorylated in response to EGF treatment.
Phosphorylation(None, EGF(), Phosphorylation, None)	EGF({'UP': u'P01133'})	PMC534114	We first assayed the ability of the mutant Gab1 proteins to become tyrosine phosphorylated in response to EGF.
Phosphorylation(None, EGF(), Phosphorylation, None)	EGF({'UP': u'P01133'})	PMC534114	We first assayed the ability of the endogenous EGFR to be tyrosine autophosphorylated in response to EGF, as well as the ability of the exogenous ErbB3 receptor to be tyrosine phosphorylated in response to stimulation with either EGF or neuregulin (NRG).
Phosphorylation(None, EGF(), Phosphorylation, None)	EGF({'UP': u'P01133'})	PMC534114	Both Gab1 and Gab1F446/472/589 are tyrosine phosphorylated in response to EGF treatment, and both form a stable complex with Shp2.
Phosphorylation(None, EGF(), Phosphorylation, None)	EGF({'UP': u'P01133'})	PMC534114	Gab1F627 and 659 becomes tyrosine phosphorylated in response to EGF treatment to levels approximately 1.5-fold higher than Gab1 as determined by densitometry, while Gab1F446/472/589 / 627 and 659 does not show EGF induced tyrosine phosphorylation in this assay.
Phosphorylation(None, EGF(), Phosphorylation, None)	EGF({'UP': u'P01133'})	PMC534114	The endogenous EGFR is tyrosine phosphorylated in response to EGF in all cell lines.
Phosphorylation(None, EGFR(), Phosphorylation, None)	EGFR({'UP': u'P00533'})	PMC534114	However, stimulation with EGF for varying time intervals revealed no significant differences in the levels of autophosphorylation of EGFR in cells expressing wild type Gab1 versus the Gab1F446/472/589 mutant.
Phosphorylation(None, EGFR(), Phosphorylation, None)	EGFR({'UP': u'P00533'})	PMC534114	Because the substrates of Shp2 are for the most part unknown, we were additionally interested in examining the state of EGFR tyrosine phosphorylation following treatment with EGF in order to determine if the failure of Gab1 to bind p85, and potentially recruit Shp2, would influence levels of EGFR autophosphorylation.
Phosphorylation(None, EGFR(), Phosphorylation, None)	EGFR({'UP': u'P00533'})	PMC534114	Levels of EGFR autophosphorylation are represented linearly following quantitation by densitometry and normalization for protein expression levels.
Phosphorylation(None, EGFR(), Phosphorylation, None)	EGFR({'UP': u'P00533'})	PMC534114	As has been previously reported, recruitment of Shp2 by Gab1 does not alter the magnitude or kinetics of tyrosine autophosphorylation of EGFR.
Phosphorylation(None, EGFR(), Phosphorylation, None)	EGFR({'UP': u'P00533'})	PMC534114	We did not detect a change in the tyrosine phosphorylation of EGFR in cells expressing Gab1 proteins that are deficient in recruitment of Shp2.
Phosphorylation(None, EGFR(), Phosphorylation, None)	EGFR({'UP': u'P00533'})	PMC534114	The experiment presented in Fig shows that all cell lines exhibit EGFR autophosphorylation in response to EGF treatment, while only cells expressing the ectopically introduced ErbB3 protein show ErbB3 tyrosine phosphorylation in response to EGF stimulation.
Phosphorylation(None, EGFR(), PhosphorylationTyrosine, None)	EGFR({'UP': u'P00533'})	PMC534114	Because the substrates of Shp2 are for the most part unknown, we were additionally interested in examining the state of EGFR tyrosine phosphorylation following treatment with EGF in order to determine if the failure of Gab1 to bind p85, and potentially recruit Shp2, would influence levels of EGFR autophosphorylation.
Phosphorylation(None, EGFR(), PhosphorylationTyrosine, None)	EGFR({'UP': u'P00533'})	PMC534114	A linear representation of the EGF induced EGFR tyrosine phosphorylation following normalization for EGFR expression levels is shown in Figure (bottom).
Phosphorylation(None, EGFR(), PhosphorylationTyrosine, None)	EGFR({'UP': u'P00533'})	PMC534114	The experiment presented in Fig shows cells stimulated with EGF over varying periods of time and cell extracts assayed for levels of EGFR tyrosine autophosphorylation.
Phosphorylation(None, EGFR(), PhosphorylationTyrosine, None)	EGFR({'UP': u'P00533'})	PMC534114	Cell extracts were prepared and analyzed for EGFR tyrosine phosphorylation.
Phosphorylation(None, EGFR(), PhosphorylationTyrosine, None)	EGFR({'UP': u'P00533'})	PMC534114	Cell extracts were prepared and analyzed for EGFR tyrosine phosphorylation and EGFR expression.
Phosphorylation(None, EGFR(), PhosphorylationTyrosine, None)	EGFR({'UP': u'P00533'})	PMC534114	Cell extracts were prepared and analyzed for EGFR tyrosine phosphorylation and EGFR expression.
Phosphorylation(None, EGFR(), PhosphorylationTyrosine, None)	EGFR({'UP': u'P00533'})	PMC534114	Cell extracts were analyzed for EGFR tyrosine phosphorylation and EGFR expression, and for ErbB3 tyrosine phosphorylation and ErbB3 expression.
Phosphorylation(None, EGFR(), PhosphorylationTyrosine, None)	EGFR({'UP': u'P00533'})	PMC534114	Cell extracts were analyzed for EGFR tyrosine phosphorylation and EGFR expression, and for ErbB3 tyrosine phosphorylation and ErbB3 expression.
Phosphorylation(None, EGFR(), PhosphorylationTyrosine, None)	EGFR({'UP': u'P00533'})	PMC534114	Cell extracts were analyzed for EGFR tyrosine phosphorylation and EGFR expression, and for ErbB3 tyrosine phosphorylation and ErbB3 expression.
Phosphorylation(None, EGFR(), PhosphorylationTyrosine, None)	EGFR({'UP': u'P00533'})	PMC534114	Cell extracts were analyzed for EGFR tyrosine phosphorylation and EGFR expression, and for ErbB3 tyrosine phosphorylation and ErbB3 expression.
Phosphorylation(None, EPHB2(), Phosphorylation, None)	EPHB2({'UP': u'P29323'})	PMC1234335	For example, E2 can induce a rapid and transient activation of the Src and Erk phosphorylation cascade through the association between cytoplasm localized ERalpha and MNAR (modulator of nongenomic activity of ER) (73).
Phosphorylation(None, ERBB3(), Phosphorylation, None)	ERBB3({'UP': u'P21860'})	PMC534114	We also demonstrate that tyrosine phosphorylation of ErbB3 may lead to recruitment and activation of PI-3 kinase and Akt in Gab1-/- MEFs.
Phosphorylation(None, ERBB3(), PhosphorylationTyrosine, None)	ERBB3({'UP': u'P21860'})	PMC534114	The experiment presented in Fig shows that all cell lines exhibit EGFR autophosphorylation in response to EGF treatment, while only cells expressing the ectopically introduced ErbB3 protein show ErbB3 tyrosine phosphorylation in response to EGF stimulation.
Phosphorylation(None, ERBB3(), PhosphorylationTyrosine, None)	ERBB3({'UP': u'P21860'})	PMC534114	Cells expressing ErbB3 show tyrosine phosphorylation in response to treatment with NRG.
Phosphorylation(None, ERBB3(), PhosphorylationTyrosine, None)	ERBB3({'UP': u'P21860'})	PMC534114	Cells were additionally stimulated with 10 ng and ml NRG and cell extracts analyzed for ErbB3 tyrosine phosphorylation.
Phosphorylation(None, ERBB3(), PhosphorylationTyrosine, None)	ERBB3({'UP': u'P21860'})	PMC534114	Cell extracts were analyzed for EGFR tyrosine phosphorylation and EGFR expression, and for ErbB3 tyrosine phosphorylation and ErbB3 expression.
Phosphorylation(None, ERBB3(), PhosphorylationTyrosine, None)	ERBB3({'UP': u'P21860'})	PMC534114	Cell extracts were analyzed for EGFR tyrosine phosphorylation and EGFR expression, and for ErbB3 tyrosine phosphorylation and ErbB3 expression.
Phosphorylation(None, ERBB3(), PhosphorylationTyrosine, None)	ERBB3({'UP': u'P21860'})	PMC534114	Cell extracts were analyzed for EGFR tyrosine phosphorylation and EGFR expression, and for ErbB3 tyrosine phosphorylation and ErbB3 expression.
Phosphorylation(None, ERBB3(), PhosphorylationTyrosine, None)	ERBB3({'UP': u'P21860'})	PMC534114	Cell extracts were analyzed for EGFR tyrosine phosphorylation and EGFR expression, and for ErbB3 tyrosine phosphorylation and ErbB3 expression.
Phosphorylation(None, ERBB3(), PhosphorylationTyrosine, None)	ERBB3({'UP': u'P21860'})	PMC534114	Cell extracts were analyzed for EGFR tyrosine phosphorylation and EGFR expression, and for ErbB3 tyrosine phosphorylation and ErbB3 expression.
Phosphorylation(None, ERK(), Phosphorylation, None)	ERK({'IP': u'IPR008349'})	PMC3178447	MEK and ERK phosphorylation were induced at intermediate concentrations of RAF inhibitor, and inhibited at much higher doses.
Phosphorylation(None, ERK(), Phosphorylation, None)	ERK({'IP': u'IPR008349'})	PMC3178447	Transactivation of RAF homo- and heterodimers is therefore responsible for induction of MEK and ERK phosphorylation by RAF inhibitors in cells with wild-type BRAF.
Phosphorylation(None, ERK(), Phosphorylation, None)	ERK({'IP': u'IPR008349'})	PMC3690480	In p110beta-RBD-DM MEFs, LPA- and S1P induced phosphorylation of AKT was strongly diminished, whereas ERK phosphorylation was undisturbed (A and A).
Phosphorylation(None, ERK(), Phosphorylation, None)	ERK({'IP': u'IPR008349'})	PMC3690480	LPA and S1P dose-dependently induced both AKT and ERK phosphorylation in wild-type cells (A and A).
Phosphorylation(None, ERK(), Phosphorylation, None)	ERK({'IP': u'IPR008349'})	PMC3690480	Neither RAC1 nor CDC42 knockdown affected LPA and S1P-induced phosphorylation of ERK or activation of either pathway induced by tyrosine kinase receptor agonists (EGF, PDGF, and insulin; E).
Phosphorylation(None, ERK(), Phosphorylation, None)	ERK({'IP': u'IPR008349'})	PMC3690480	(B) LPA and S1P-induced phosphorylation of AKT and ERK is sensitive to PTX.
Phosphorylation(None, GAB1(), Phosphorylation, None)	GAB1({'UP': u'Q13480'})	PMC534114	Treatment with EGF induced tyrosine phosphorylation of the exogenous Gab1 protein expressed in the Gab1 -/ - MEFs at levels similar to endogenous Gab1 in wild type MEFs.
Phosphorylation(None, GAB1(), Phosphorylation, None)	GAB1({'UP': u'Q13480'})	PMC534114	Quantitation following densitometry indicates that Gab1F627 and 659 is reproducibly tyrosine phosphorylated to levels approximately 1.5-fold higher than Gab1.
Phosphorylation(None, GAB1(), Phosphorylation, None)	GAB1({'UP': u'Q13480'})	PMC534114	Additionally, we demonstrated that Gab1 -/ - MEFs that express wild type Gab1 display Gab1 tyrosine phosphorylation in response to EGF treatment, while Gab1 -/ - control cells or those expressing ErbB3 do not show Gab1 phosphorylation.
Phosphorylation(None, GAB1(), Phosphorylation, None)	GAB1({'UP': u'Q13480'})	PMC534114	Gab1F627 and 659 becomes tyrosine phosphorylated in response to EGF treatment to levels approximately 1.5-fold higher than Gab1 as determined by densitometry, while Gab1F446/472/589 / 627 and 659 does not show EGF induced tyrosine phosphorylation in this assay.
Phosphorylation(None, GAB1(), PhosphorylationTyrosine, None)	GAB1({'UP': u'Q13480'})	PMC534114	MEFs derived from Gab1-/- or wild type (WT) embryos were stimulated with EGF and assayed for Gab1 tyrosine phosphorylation, for activation of PI-3 kinase and for Akt stimulation.
Phosphorylation(None, GAB1(), PhosphorylationTyrosine, None)	GAB1({'UP': u'Q13480'})	PMC534114	Additionally, we demonstrated that Gab1 -/ - MEFs that express wild type Gab1 display Gab1 tyrosine phosphorylation in response to EGF treatment, while Gab1 -/ - control cells or those expressing ErbB3 do not show Gab1 phosphorylation.
Phosphorylation(None, GAB1(), PhosphorylationTyrosine, None)	GAB1({'UP': u'Q13480'})	PMC534114	Cell extracts were prepared and analyzed for Gab1 tyrosine phosphorylation and Gab1 expression.
Phosphorylation(None, GAB1(), PhosphorylationTyrosine, None)	GAB1({'UP': u'Q13480'})	PMC534114	Cell extracts were prepared and analyzed for Gab1 tyrosine phosphorylation and Gab1 expression.
Phosphorylation(None, GAB1(), PhosphorylationTyrosine, None)	GAB1({'UP': u'Q13480'})	PMC534114	Both WT MEFs and cells expressing exogenous Gab1 show Gab1 tyrosine phosphorylation in response to EGF treatment.
Phosphorylation(None, GAB1(), PhosphorylationTyrosine, None)	GAB1({'UP': u'Q13480'})	PMC534114	Both WT MEFs and cells expressing exogenous Gab1 show Gab1 tyrosine phosphorylation in response to EGF treatment.
Phosphorylation(None, GAB1(), PhosphorylationTyrosine, None)	GAB1({'UP': u'Q13480'})	PMC534114	Cell extracts were prepared and analyzed for Gab1 tyrosine phosphorylation, Gab1 co-immunoprecipitation with p85, p85 expression, Gab1 co-immunoprecipitation with Shp2, and Gab1 expression.
Phosphorylation(None, GAB1(), PhosphorylationTyrosine, None)	GAB1({'UP': u'Q13480'})	PMC534114	Cell extracts were prepared and analyzed for Gab1 tyrosine phosphorylation, Gab1 co-immunoprecipitation with p85, p85 expression, Gab1 co-immunoprecipitation with Shp2, and Gab1 expression.
Phosphorylation(None, GAB1(), PhosphorylationTyrosine, None)	GAB1({'UP': u'Q13480'})	PMC534114	Cell extracts were prepared and analyzed for Gab1 tyrosine phosphorylation, Gab1 co-immunoprecipitation with p85, p85 expression, Gab1 co-immunoprecipitation with Shp2, and Gab1 expression.
Phosphorylation(None, GAB1(), PhosphorylationTyrosine, None)	GAB1({'UP': u'Q13480'})	PMC534114	Cell extracts were prepared and analyzed for Gab1 tyrosine phosphorylation, Gab1 co-immunoprecipitation with p85, p85 expression, Gab1 co-immunoprecipitation with Shp2, and Gab1 expression.
Phosphorylation(None, GAB1(), PhosphorylationTyrosine, None)	GAB1({'UP': u'Q13480'})	PMC534114	Cell extracts were prepared and analyzed for Gab1 tyrosine phosphorylation, Gab1-Shp2 co-immunoprecipitation and Gab1 expression.
Phosphorylation(None, GAB1(), PhosphorylationTyrosine, None)	GAB1({'UP': u'Q13480'})	PMC534114	Cell extracts were prepared and analyzed for Gab1 tyrosine phosphorylation, Gab1-Shp2 co-immunoprecipitation and Gab1 expression.
Phosphorylation(None, GAB1(), PhosphorylationTyrosine, None)	GAB1({'UP': u'Q13480'})	PMC534114	Cell extracts were analyzed for Gab1 tyrosine phosphorylation and Gab1 expression.
Phosphorylation(None, GAB1(), PhosphorylationTyrosine, None)	GAB1({'UP': u'Q13480'})	PMC534114	Cell extracts were analyzed for Gab1 tyrosine phosphorylation and Gab1 expression.
Phosphorylation(None, GAB1(), PhosphorylationTyrosine, None)	GAB1({'UP': u'Q13480'})	PMC534114	Cells rescued with wild type Gab1 exhibit Gab1 tyrosine phosphorylation in response to EGF treatment, while Gab1 -/ - cells and Gab1 deficient cells expressing ErbB3 do not.
Phosphorylation(None, LPA(), Phosphorylation, None)	LPA({'UP': u'P08519'})	PMC3690480	Knockdown of RAC1 strongly impacted LPA and S1P-induced AKT phosphorylation, knockdown of CDC42 had only minor effects, and combination knockdown of both RAC1 and CDC42 had little additional effect compared to RAC1 knockdown alone (D).
Phosphorylation(None, MAPK3(), Phosphorylation, None)	MAPK3({'UP': u'P27361'})	PMC4345513	Inhibition of the phosphatidylinositol 3-kinase (PI3K) / Akt pathway abrogated active Ras induced up regulation of MKP3 expression, leading to the rescue of Erk1 and 2 phosphorylation.
Phosphorylation(None, MAPK3(), Phosphorylation, None)	MAPK3({'UP': u'P27361'})	PMC4345513	Despite the continual increase in the level of active Ras, the levels of Erk1 and 2 phosphorylation gradually decreased after peaking at 12 h after doxycycline addition.
Phosphorylation(None, MAPK3(), Phosphorylation, None)	MAPK3({'UP': u'P27361'})	PMC4345513	The level of Erk1 and 2 phosphorylation was increased by FGF2 in both untreated and treated cells with doxycycline for 12 h, but not in cells treated with doxycycline for 48 h, although the basal Erk1 and 2 phosphorylation level was similar to that in cells treated with doxycycline for 12 h. Furthermore, the phosphorylation of Erk1 and 2 down-stream targets, such as p90 ribosomal S6 kinase (RSK; MAPKAPK1A) and transcription factor Elk-1, was not increased by FGF2 in cells treated with doxycycline for 48 h.
Phosphorylation(None, MAPK3(), Phosphorylation, None)	MAPK3({'UP': u'P27361'})	PMC4345513	The level of Erk1 and 2 phosphorylation was increased by FGF2 in both untreated and treated cells with doxycycline for 12 h, but not in cells treated with doxycycline for 48 h, although the basal Erk1 and 2 phosphorylation level was similar to that in cells treated with doxycycline for 12 h. Furthermore, the phosphorylation of Erk1 and 2 down-stream targets, such as p90 ribosomal S6 kinase (RSK; MAPKAPK1A) and transcription factor Elk-1, was not increased by FGF2 in cells treated with doxycycline for 48 h.
Phosphorylation(None, MAPK3(), Phosphorylation, None)	MAPK3({'UP': u'P27361'})	PMC4345513	In contrast, Erk1 and 2 phosphorylation was marked in the cytosol, but sparse in the nucleus of doxycycline treated cells.
Phosphorylation(None, MAPK3(), PhosphorylationThreonine, None)	MAPK3({'UP': u'P27361'})	PMC4345513	MEK is a dual-specificity protein kinase that phosphorylates Erk1 and 2 (p42 and p44 MAP kinase) on both threonine and tyrosine in a conserved Thr-X-Tyr motif,.
Phosphorylation(None, MAPK3(), PhosphorylationTyrosine, None)	MAPK3({'UP': u'P27361'})	PMC4345513	MEK is a dual-specificity protein kinase that phosphorylates Erk1 and 2 (p42 and p44 MAP kinase) on both threonine and tyrosine in a conserved Thr-X-Tyr motif,.
Phosphorylation(None, MEK(), Phosphorylation, None)	MEK({})	PMC3178447	MEK and ERK phosphorylation were induced at intermediate concentrations of RAF inhibitor, and inhibited at much higher doses.
Phosphorylation(None, MEK(), Phosphorylation, None)	MEK({})	PMC3178447	Transactivation of RAF homo- and heterodimers is therefore responsible for induction of MEK and ERK phosphorylation by RAF inhibitors in cells with wild-type BRAF.
Phosphorylation(None, MMK1(), Phosphorylation, None)	MMK1({'UP': u'Q07176'})	PMC1234335	Indeed, the kinases ERK1 and 2, p38 MAPK, protein kinase A, and IKKalpha can phosphorylate both ER and SRC family members (7, 24, 29, 35, 50, 56, 75).
Phosphorylation(None, Malme_3M(), Phosphorylation, None)	Malme_3M({})	PMC3178447	Phosphorylation and expression of the indicated proteins were assayed by immunoblotting.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	The CC mutant appeared to be less effective at supporting SRC-3 phosphorylation than wild-type ERalpha was (lanes 3 and 4) or the EG mutant, even though the CC mutant binds to SRC-3 as well as does the wild-type receptor.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	For example, TNF-alpha induces phosphorylation and nuclear translocation of SRC-3, and nuclear SRC-3 is hyperphosphorylated compared to the cytoplasmic fraction (74), indicating that SRC-3 may be partially phosphorylated in the cytoplasm and further phosphorylated after translocation to the nucleus and recruitment to the promoter.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	These data indicated that an intact coactivator binding groove within the LBD is essential for E2 induced SRC-3 phosphorylation and imply that a direct interaction between SRC-3 and ERalpha is necessary.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	The kinetics of E2 induced SRC-3 phosphorylation also were assessed in HEK293T cells cotransfected with Flag tagged SRC-3 and ERalpha.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	To determine whether E2 induced SRC-3 phosphorylation is dependent on the presence of ER, HEK293T cells transfected with SRC-3 together with or without either ERalpha or ERbeta were treated with E2.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	How E2 induces phosphorylation of SRC-3 is poorly understood.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	In contrast, estrogen may attenuate cellular responses to inflammatory stimuli, such as the cytokine TNF-alpha, because of E2 induced phosphorylation of SRC-3 that renders the coactivator less effective at cytokine target genes.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Interestingly, this ERalpha AF-1 phosphorylation mutant could still induce SRC-3 phosphorylation, at a level comparable to the wild-type ERalpha,4 C), suggesting that phosphorylation of ERalpha is not a prerequisite for promoting SRC-3 phosphorylation.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Fig. 4A,4 A, N282 did not support E2 induced SRC-3 phosphorylation (lanes 3 and 4), which is not surprising since N282 lacks an LBD and is not responsive to E2.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Whether E2 induced SRC-3 phosphorylation is mediated through a " genomic " or " nongenomic " activity of E2 and its dependence on ER is unclear at present.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	It is possible that there is a small amount of the DeltaNLS mutant receptor localized in the nucleus (78) which may contribute to SRC-3 phosphorylation.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	SERMs do not induce SRC-3 phosphorylation.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	However, the status of SRC-3 phosphorylation at each of the six sites in the presence of high levels of HER2 has not been investigated yet.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Fig. 2C,2 C, in the presence of siERalpha, expression of endogenous ERalpha was greatly reduced (lanes 3 and 4, row 4), and E2 induced phosphorylation of endogenous SRC-3 was abolished (lanes 3 and 4, rows 1 to 3).
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Previous data indicated that E2 induced SRC-3 phosphorylation requires the formation of a complex containing SRC-3 and ER.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	However, both the AF-1 and LBD and AF -2 domains of ERalpha are essential for maximal E2 induction of SRC-3 phosphorylation.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	In order to investigate whether this surface is essential for E2 induced SRC-3 phosphorylation, several mutations which disrupt the direct interaction of ERalpha with coactivator were examined for their ability to impact E2 induction of SRC-3 phosphorylation in HEK293T cells.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Nuclear localization of ERalpha is not required for E2 induced SRC-3 phosphorylation.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	These results indicated that E2 could alter the electrophoretic mobility of the wild-type SRC-3 but not its phosphorylation-site A6 mutant, implying that the E2 induced mobility change of SRC-3 is the result of SRC-3 phosphorylation.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Forty-eight hours posttransfection, cells were treated with E2 (10 nM, 1 h), and phosphorylation of immunoprecipitated endogenous SRC-3 was determined using SRC-3 phosphorylation state specific antibodies as described above.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Six SRC-3 phosphorylation sites have been identified, and these can be induced by steroids, cytokines, and growth factors, involving multiple kinase signaling pathways.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	It has been shown that both ER and SRC-3 shuttle between the cytoplasm and the nucleus (14, 39, 53), and the collective data indicate that SRC-3 phosphorylation can occur in both cytoplasm and nucleus and that it generally promotes nuclear localization of SRC-3 (53, 68, 71, 74).
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	We found that both the ERalpha AF-1 and AF-2 domains are necessary for robust induction of SRC-3 phosphorylation by E2 and that a direct interaction between the ERalpha LBD and coactivator is required.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	As shown in Fig. 3A, P did not induce SRC-3 phosphorylation in the presence of PR-B (lanes 5 and 6), although in parallel experiments E2 induced ER dependent SRC-3 phosphorylation (lanes 3 and 4).
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	In order to investigate whether other hormones and their cognate nuclear receptors can induce SRC-3 phosphorylation, HEK293T cells transfected with an SRC-3 expression vector in the absence or presence of progesterone receptor B (PR-B) plasmid were treated with progesterone (P; 10 nM, 1 h).
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	The inability of the SERMs, 4HT and raloxifene, to induce SRC-3 phosphorylation is consistent with both of these points.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	The coactivator binding groove of ERalpha is required for E2 induced SRC-3 phosphorylation.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Previously, we showed that androgen can induce SRC-3 phosphorylation (75), but in this report we demonstrate that neither PR-B nor GR is able to induce phosphorylation of any of the six known SRC-3 phosphorylation sites in response to their cognate ligands.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	As a negative control, E2 induced SRC-3 phosphorylation was not observed when the SRC-3 phosphorylation mutant A6 was used, even though the A6 form of SRC-3, like wild-type SRC-3, could still bind to ERalpha in response to E2.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	These data indicated that different steroids and their receptors have differential effects on SRC-3 phosphorylation.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	To determine whether phosphorylation of SRC-3 can take place in the cytoplasm, an ERalpha mutant (ERalphaDeltaNLS) lacking amino acids 250 to 303, which encompass the ERalpha NLS, was used.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Although our current data can not distinguish between these models, or whether the ER is attached to the membrane (31, 52, 62), our results indicate that phosphorylation of three of the major phosphorylation sites of the ERalpha AF-1 domain is not a prerequisite for SRC-3 phosphorylation.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Fig. 2D,2 D, SRC-3 phosphorylation could be observed by 15 min after E2 treatment, represented by phosphorylation at sites T24, S505, and S543 (lanes 3 to 7, rows 1 to 3).
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	As shown in Fig. 3A, P did not induce SRC-3 phosphorylation in the presence of PR-B (lanes 5 and 6), although in parallel experiments E2 induced ER dependent SRC-3 phosphorylation (lanes 3 and 4).
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	In addition to its phosphorylation by an E2 and ER-dependent pathway, SRC-3 phosphorylation also can be induced by growth factors and cytokines (17, 75).
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	AF-1 and LBD and AF -2 of ERalpha are required for maximal induction of SRC-3 phosphorylation.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	It has been shown that E2 and the synthetic androgen R1881 can induce SRC-3 phosphorylation in the presence of ER and androgen receptor, respectively 2) (75).
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Nonetheless, the differences between ER and AR and GR and PR and their cognate ligands, relative to their abilities to induce SRC-3 phosphorylation, indicate that the relative importance of SRC-3 phosphorylation at the six sites tested can be receptor specific.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Consistent with the model that E2 induced coactivator phosphorylation can be mediated through the transcription independent and " nongenomic " signaling of ER, we showed that ERalpha nuclear localization is not required for promoting SRC-3 phosphorylation.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	In contrast, SRC-3 phosphorylation was still induced when a control siRNA against luciferase (siLuc) was used (lanes 1 and 2, rows 1 to 3).
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	For example, TNF-alpha induces phosphorylation and nuclear translocation of SRC-3, and nuclear SRC-3 is hyperphosphorylated compared to the cytoplasmic fraction (74), indicating that SRC-3 may be partially phosphorylated in the cytoplasm and further phosphorylated after translocation to the nucleus and recruitment to the promoter.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	The LXXLL motifs of SRC-3 are required for E2 induced SRC-3 phosphorylation.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	These observations likely result from the different affinities of various SRC-3 phosphorylation site mutants for other coregulators and transcription factors such as CBP, CARM1, ERalpha, and NF-kappaB (75).
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	SRC-3 phosphorylation state specific antibodies were used to determine the level of phosphorylation of immunoprecipitated Flag tagged SRC-3.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Six in vivo SRC-3 phosphorylation sites have been identified,1 A), and phosphorylation state specific antibodies against each site have been generated and validated (75).
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Mutations in the coactivator binding groove of the ERalpha ligand binding domain inhibit E2 stimulated SRC-3 phosphorylation, as do mutations in the nuclear receptor interacting domain of SRC-3, suggesting that ERalpha must directly contact SRC-3 for this posttranslational modification to take place.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Our model, in which E2 induced SRC-3 phosphorylation occurs in a complex with either ERalpha or ERbeta, suggests that the high proximity of receptor and coactivator may enable the same kinase to efficiently phosphorylate SRC-3 and ER in response to E2.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Selectivity of hormones and nuclear receptors for induction of SRC-3 phosphorylation.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	As for wild-type ERalpha, the mutant was able to induce SRC-3 phosphorylation at all six sites,7 B), indicating that nuclear localization of ERalpha may not be required for inducing SRC-3 phosphorylation in response to E2.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	These results indicated that E2 induced SRC-3 phosphorylation requires either form of ER.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Cells were then treated, and SRC-3 phosphorylation was examined.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Nonetheless, the differences between ER and AR and GR and PR and their cognate ligands, relative to their abilities to induce SRC-3 phosphorylation, indicate that the relative importance of SRC-3 phosphorylation at the six sites tested can be receptor specific.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	It is highly probable that the stimuli encountered by SRC-3, and hence its phosphorylation pattern and coactivator activity, will be cell and tissue specific.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Mutations of the ERalpha DNA binding domain did not block this rapid E2 dependent SRC-3 phosphorylation.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Using phosphospecific antibodies for six phosphorylation sites, we investigated the mechanisms involved in estradiol (E2) - induced SRC-3 phosphorylation and found that this occurs only when either activated estrogen receptor alpha (ERalpha) or activated ERbeta is present.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Moreover, steroid induced phosphorylation of SRC-3 is nuclear receptor specific.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	In cells that express ERalpha, E2 induces SRC-3 phosphorylation at all six phosphorylation sites identified (75).
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Previously, we showed that androgen can induce SRC-3 phosphorylation (75), but in this report we demonstrate that neither PR-B nor GR is able to induce phosphorylation of any of the six known SRC-3 phosphorylation sites in response to their cognate ligands.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	For example, 17beta-estradiol (E2) induces SRC-3 phosphorylation at all six sites, while tumor necrosis factor alpha (TNF-alpha) induces phosphorylation of all but the serine-860 (S860) site (75).
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Our model, in which E2 induced SRC-3 phosphorylation occurs in a complex with either ERalpha or ERbeta, suggests that the high proximity of receptor and coactivator may enable the same kinase to efficiently phosphorylate SRC-3 and ER in response to E2.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	As shown in Fig. 2A and B, E2 induced SRC-3 phosphorylation at all six sites (T24, S505, S543, S857, S860, and S867) in cells transfected with an expression vector for wild-type ERalpha or ERbeta, but not in cells transfected with an empty expression vector.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	This confirmed the data from transient-transfection experiments indicating that E2 induced phosphorylation of SRC-3 requires ER.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Here we show that E2 induced SRC-3 phosphorylation requires a direct interaction between SRC-3 and ERalpha but does not require DNA binding and nuclear localization of ERalpha, indicating a " nongenomic " action of this receptor.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Fig. 6,6, unlike the wild-type SRC-3 (lanes 2 and 3), the AAA mutant could not be phosphorylated in response to E2 treatment (lanes 4 and 5), substantiating the notion that a direct ligand induced interaction between coactivator and ERalpha is necessary for E2 dependent SRC-3 phosphorylation.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Estradiol induced SRC-3 phosphorylation requires ER.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	The results above demonstrated that ER is required for E2 induced SRC-3 phosphorylation and implied that an interaction, either direct or indirect, between ER and SRC-3 is required.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	It is possible that E2 bound ERalpha can first recruit kinases via its AF-1 or AF-2 domain, allowing subsequent phosphorylation of SRC-3, or vice versa.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Whether E2 dependent SRC-3 phosphorylation requires ERalpha to be bound to DNA was investigated.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	These results indicated that E2 could alter the electrophoretic mobility of the wild-type SRC-3 but not its phosphorylation-site A6 mutant, implying that the E2 induced mobility change of SRC-3 is the result of SRC-3 phosphorylation.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Different stimuli induce distinct patterns of SRC-3 phosphorylation, and mutations at different phosphorylation sites have different downstream effects.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Here we report that E2 induced SRC-3 phosphorylation occurs within minutes and requires a direct interaction between SRC-3 and ERalpha but does not require nuclear localization or the DNA binding activity of ERalpha.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Fig. 5B,5 B, the ERalpha single mutants (K, V, or L) were severely compromised in their ability to support E2 induced SRC-3 phosphorylation (lanes 5 to 10, row 1), while the triple mutant (KVL) was unable to induce any phosphorylation of SRC-3 (lanes 3 and 4, row 1).
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Together these data demonstrate that E2 induced SRC-3 phosphorylation is dependent on a direct interaction between SRC-3 and ERalpha and can occur outside of the nucleus.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	To further test the role of AF-1 in SRC-3 phosphorylation, an ERalpha phosphorylation mutant (S104A/S106A/S118A as 3A) was used to determine whether phosphorylation of AF-1 is required.
Phosphorylation(None, NCOA3(), Phosphorylation, None)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	As a negative control, E2 induced SRC-3 phosphorylation was not observed when the SRC-3 phosphorylation mutant A6 was used, even though the A6 form of SRC-3, like wild-type SRC-3, could still bind to ERalpha in response to E2.
Phosphorylation(None, NCOA3(), PhosphorylationSerine, 505)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Representative data for SRC-3 phosphorylation at S505 and S867 were shown, and other sites had a similar pattern (data not shown).
Phosphorylation(None, NCOA3(), PhosphorylationSerine, 505)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	The 179C mutant supported only minimal E2 induced SRC-3 phosphorylation at S505 but not at other sites as represented by T24, S543, and S867.
Phosphorylation(None, NCOA3(), PhosphorylationSerine, 867)	NCOA3({'UP': u'Q9Y6Q9'})	PMC1234335	Representative data for SRC-3 phosphorylation at S505 and S867 were shown, and other sites had a similar pattern (data not shown).
Phosphorylation(None, NUP43(), PhosphorylationThreonine, None)	NUP43({'UP': u'Q8NFH3'})	PMC4345513	MEK is a dual-specificity protein kinase that phosphorylates Erk1 and 2 (p42 and p44 MAP kinase) on both threonine and tyrosine in a conserved Thr-X-Tyr motif,.
Phosphorylation(None, NUP43(), PhosphorylationTyrosine, None)	NUP43({'UP': u'Q8NFH3'})	PMC4345513	MEK is a dual-specificity protein kinase that phosphorylates Erk1 and 2 (p42 and p44 MAP kinase) on both threonine and tyrosine in a conserved Thr-X-Tyr motif,.
Phosphorylation(None, PLX(), Phosphorylation, None)	PLX({'UP': u'P81565'})	PMC3178447	In contrast, it did not affect the phosphorylation of the PLX resistant CRAFT421M mutant.
Phosphorylation(None, PTPN11(), PhosphorylationTyrosine, None)	PTPN11({'UP': u'Q06124'})	PMC534114	Cell extracts were prepared and analyzed for Gab1 tyrosine phosphorylation, Gab1-Shp2 co-immunoprecipitation and Gab1 expression.
Phosphorylation(None, RAF1(), PhosphorylationSerine, 338)	RAF1({'UP': u'P04049'})	PMC3178447	Phosphorylation of CRAF at S338 and S621 has been correlated with its activation.
Phosphorylation(None, RAF1(), PhosphorylationSerine, 621)	RAF1({'UP': u'P04049'})	PMC3178447	Phosphorylation of CRAF at S338 and S621 has been correlated with its activation.
Phosphorylation(None, RPS6KA(), Phosphorylation, None)	RPS6KA({'UP': u'P18652'})	PMC3178447	Induction of ERK signaling by PLX4720 was rapid, reversible, and associated with increased phosphorylation of the ERK substrate RSK.
Phosphorylation(None, SRC_3_AAA_mutant(), Phosphorylation, None)	SRC_3_AAA_mutant({})	PMC1234335	To investigate whether the SRC-3-AAA mutant can be phosphorylated in response to E2, plasmids for the SRC 3 mutant and ERalpha were transfected into HEK293T cells.
Phosphorylation(None, TNF(), Phosphorylation, None)	TNF({'UP': u'Q9BEA1'})	PMC1234335	However, the precise extent to which each of the six known sites of SRC-3 is phosphorylated in each component is unknown.
Phosphorylation(None, albA2(), Phosphorylation, None)	albA2({'UP': u'O28323'})	PMC1234335	To further test the role of AF-1 in SRC-3 phosphorylation, an ERalpha phosphorylation mutant (S104A/S106A/S118A as 3A) was used to determine whether phosphorylation of AF-1 is required.
Phosphorylation(None, albA2(), Phosphorylation, None)	albA2({'UP': u'O28323'})	PMC1234335	Interestingly, this ERalpha AF-1 phosphorylation mutant could still induce SRC-3 phosphorylation, at a level comparable to the wild-type ERalpha,4 C), suggesting that phosphorylation of ERalpha is not a prerequisite for promoting SRC-3 phosphorylation.
Phosphorylation(None, ar(), Phosphorylation, None)	ar({'UP': u'Q7T1K4'})	PMC1234335	Conceivably, PR or GR and their cognate ligands may induce phosphorylation of SRC-3 at sites distinct from those known to be phosphorylated in response to ER or AR ligands.
Phosphorylation(None, esr1(), Phosphorylation, None)	esr1({'UP': u'P81559'})	PMC1234335	In order to investigate the contribution of the AF-1 and AF-2 domains of ERalpha for E2 induced SRC-3 phosphorylation, wild-type full-length ERalpha and an ERalpha truncation mutant, ERalpha1-282 (N282) lacking AF-2 / LBD or ERalpha179-595 (179C) lacking AF-1, together with Flag tagged SRC-3, were transfected into HEK293T cells.
Phosphorylation(None, esr1(), Phosphorylation, None)	esr1({'UP': u'P81559'})	PMC1234335	In addition to its phosphorylation by an E2 and ER-dependent pathway, SRC-3 phosphorylation also can be induced by growth factors and cytokines (17, 75).
Phosphorylation(None, esr1(), Phosphorylation, None)	esr1({'UP': u'P81559'})	PMC1234335	Conceivably, PR or GR and their cognate ligands may induce phosphorylation of SRC-3 at sites distinct from those known to be phosphorylated in response to ER or AR ligands.
Phosphorylation(None, esr1(), Phosphorylation, None)	esr1({'UP': u'P81559'})	PMC1234335	Interestingly, this ERalpha AF-1 phosphorylation mutant could still induce SRC-3 phosphorylation, at a level comparable to the wild-type ERalpha,4 C), suggesting that phosphorylation of ERalpha is not a prerequisite for promoting SRC-3 phosphorylation.
Phosphorylation(None, esr1(), Phosphorylation, None)	esr1({'UP': u'P81559'})	PMC1234335	Our model, in which E2 induced SRC-3 phosphorylation occurs in a complex with either ERalpha or ERbeta, suggests that the high proximity of receptor and coactivator may enable the same kinase to efficiently phosphorylate SRC-3 and ER in response to E2.
Phosphorylation(None, esr1(), Phosphorylation, None)	esr1({'UP': u'P81559'})	PMC1234335	To further test the role of AF-1 in SRC-3 phosphorylation, an ERalpha phosphorylation mutant (S104A/S106A/S118A as 3A) was used to determine whether phosphorylation of AF-1 is required.
Phosphorylation(None, p44_MAP(), PhosphorylationThreonine, None)	p44_MAP({})	PMC4345513	MEK is a dual-specificity protein kinase that phosphorylates Erk1 and 2 (p42 and p44 MAP kinase) on both threonine and tyrosine in a conserved Thr-X-Tyr motif,.
Phosphorylation(None, p44_MAP(), PhosphorylationTyrosine, None)	p44_MAP({})	PMC4345513	MEK is a dual-specificity protein kinase that phosphorylates Erk1 and 2 (p42 and p44 MAP kinase) on both threonine and tyrosine in a conserved Thr-X-Tyr motif,.
Phosphorylation(None, src(), Phosphorylation, None)	src({'UP': u'Q1JPZ3'})	PMC1234335	Hormones and growth factors induce SRC phosphorylation, but the mechanisms are largely unknown.
